Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

154634333 185215 0 None - 1 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185215 0 None - 1 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 112811 5 None - 1 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112811 5 None - 1 Human 9.0 pEC50 = 9.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 184875 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184875 0 None - 1 Human 7.0 pEC50 = 7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
12138435 68057 29 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 68057 29 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
70696510 75303 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 75303 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
70682869 77381 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 77381 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
5281605 205732 114 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 205732 114 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
145950576 162879 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 162879 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
70687103 77702 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 77702 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
70687102 77701 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 77701 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
5281855 202843 109 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 202843 109 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
53257379 68061 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 68061 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
135403802 26531 56 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26531 56 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
411 2593 92 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2593 92 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2593 92 None -144 2 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
4488 203021 110 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 203021 110 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
70692387 75310 2 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037465 75310 2 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 259 1 2 2 3.0 Cc1c(C(=O)O)[nH]c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
66561718 75307 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 75307 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
154634327 184739 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184739 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
153273978 195926 4 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 195926 4 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 195926 4 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
70681838 75299 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 75299 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70689185 77705 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
CHEMBL2089225 77705 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 337 2 4 3 4.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(C(F)(F)F)cc1 10.1021/ml300076u
72103 43408 28 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL150764 43408 28 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 356 5 4 4 2.1 CCCCc1cc2c(=O)cc(C(=O)O)[nH]c2c2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634331 184548 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 184548 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145951566 162765 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162765 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145951566 162765 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162765 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
145959592 162350 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 162350 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
411 2593 92 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2593 92 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2593 92 None -144 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
135399235 4134 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 4134 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 4134 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 4134 60 None -18 3 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
12533774 185518 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 185518 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
53258793 68070 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 68070 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281672 56554 121 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56554 121 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
70694439 75305 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 75305 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
154634337 185333 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 185333 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
16103462 68069 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 68069 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
12138434 68062 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 68062 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
66561717 75301 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 75301 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
135399235 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
135399235 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
70691268 77709 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 77709 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135399235 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4134 60 None -18 3 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
151577785 186553 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 186553 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
45093111 77706 9 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089226 77706 9 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 208 1 3 4 1.9 Cc1c(C(=O)O)oc2cc(O)c(O)cc12 10.1021/ml300076u
154634333 185215 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185215 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
154634330 185952 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 185952 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 185997 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185997 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
9990345 68065 35 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 68065 35 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
70697499 77692 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089195 77692 1 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 297 3 3 4 3.1 Cc1ccc(Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
110720191 162457 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 162457 2 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
70692386 75308 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 75308 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 68069 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 68069 19 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
73157 195359 30 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 195359 30 None - 1 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
154634326 185092 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185092 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
149708825 186391 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 186391 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
53258795 68071 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 68071 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145959306 162315 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 162315 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 162737 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162737 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
2920 2997 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 2997 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 2997 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 2997 103 None 3388 2 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
154634332 185127 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185127 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145949189 162737 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162737 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
135399235 4134 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
2919 4134 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
5722 4134 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
CHEMBL28079 4134 60 None -18 3 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 assessed as induction of beta-arrestin recruitmentAgonist activity at human GPR35 assessed as induction of beta-arrestin recruitment
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.7b00510
70693381 77697 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
CHEMBL2089217 77697 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 269 2 4 3 2.9 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccccc1 10.1021/ml300076u
145958445 162131 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 162131 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
152243845 184899 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 184899 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
145955278 162559 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 162559 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
152550147 185328 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 185328 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634334 185425 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 185425 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70681838 75299 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
CHEMBL2037453 75299 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 290 1 1 3 4.0 Cc1sc2c(C)c(C(=O)O)sc2c1Br 10.1016/j.bmcl.2012.04.057
70687102 77701 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
CHEMBL2089221 77701 0 None - 1 Human 4.7 pEC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1ccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)cc1 10.1021/ml300076u
53258795 68071 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 68071 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
5281605 205732 114 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 205732 114 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
53258796 68072 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 68072 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
3715518 29758 7 None -13 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
CHEMBL1386881 29758 7 None -13 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 379 9 1 3 5.2 COc1ccc(CNCCC(c2ccc(F)cc2)c2ccc(OC)cc2)cc1 nan
119405 97144 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 97144 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
150386356 185146 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 185146 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
119405 97144 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
CHEMBL267855 97144 76 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 193 1 4 3 1.3 O=C(O)c1cc2cc(O)c(O)cc2[nH]1 10.1021/ml300076u
73157 195359 30 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 195359 30 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
152684818 184992 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 184992 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
66561718 75307 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037462 75307 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 275 2 1 4 4.0 Cc1c(C(=O)O)sc2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
70687103 77702 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
CHEMBL2089222 77702 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 337 2 4 3 4.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(Cl)cc(Cl)c1 10.1021/ml300076u
66561717 75301 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037456 75301 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 356 1 2 4 3.9 O=C(O)c1sc2c(Br)c(Br)sc2c1O 10.1016/j.bmcl.2012.04.057
70695483 77698 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 77698 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
70689184 77700 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 77700 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
154634327 184739 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184739 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
154634326 185092 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185092 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70691267 77704 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
CHEMBL2089224 77704 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccc(Cl)cc1 10.1021/ml300076u
944642 59120 11 None -30 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
CHEMBL1698243 59120 11 None -30 4 Human 4.6 pEC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 324 5 2 4 4.2 CCOc1ccc(-c2n[nH]c(C)c2-c2ccc(OC)cc2)c(O)c1 nan
70692386 75308 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037463 75308 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 280 2 1 4 4.7 Cc1c(C(=O)O)sc2c(-c3ccsc3)csc12 10.1016/j.bmcl.2012.04.057
70690212 75304 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
CHEMBL2037459 75304 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 302 2 1 3 4.3 O=C(O)c1sc2c(Br)csc2c1C1CC1 10.1016/j.bmcl.2012.04.057
66561793 75311 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 75311 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
150149078 186344 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 186344 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
3884 44498 77 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44498 77 None - 1 Human 5.6 pEC50 = 5.6 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
152727536 184487 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 184487 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634322 185380 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 185380 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
5281855 202843 109 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 202843 109 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
57134579 162632 18 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 162632 18 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145957901 162075 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 162075 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145957901 162075 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 162075 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
5281672 56554 121 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56554 121 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
145951357 162764 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162764 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
154634320 186610 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186610 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
70683937 75041 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 75041 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145951357 162764 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162764 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
12138435 68057 29 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 68057 29 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
5215 2386 132 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2386 132 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2386 132 None -1 4 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
154634315 184878 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 184878 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
56646802 68058 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 68058 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
135399235 4134 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4134 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4134 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4134 60 None -18 3 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
16103482 68066 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 68066 1 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
70695483 77698 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
CHEMBL2089218 77698 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 303 2 4 3 3.6 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccc(Cl)c1 10.1021/ml300076u
145971743 163104 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 163104 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
145971743 163104 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 163104 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
11674067 68059 28 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 68059 28 None - 1 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
145953959 162677 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 162677 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
70686064 75300 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 75300 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
154634324 185711 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185711 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
70686065 75309 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 75309 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
145971240 163087 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 163087 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145971240 163087 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 163087 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5491415 75292 19 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 75292 19 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
154634318 185999 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 185999 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
70696510 75303 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
CHEMBL2037458 75303 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 296 1 1 3 4.1 O=C(O)c1sc2c(Br)csc2c1Cl 10.1016/j.bmcl.2012.04.057
2918 2204 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
3845 2204 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
CHEMBL299155 2204 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
DB11937 2204 126 None -2630 4 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assayAgonist activity at human GPR35 expressed in CHO cells assessed as increase in intracellular Ca2+ measured over 20 secs by Aequorin assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm4009373
70691265 77694 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
CHEMBL2089197 77694 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 325 4 3 5 2.9 Cc1ccc(C(=O)Cn2c(C(=O)O)cc3cc(O)c(O)cc32)cc1 10.1021/ml300076u
4488 203021 110 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 203021 110 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
145956623 162013 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 162013 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
145956623 162013 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 162013 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
70682865 77695 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
CHEMBL2089199 77695 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 271 1 4 3 2.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1Br 10.1021/ml300076u
135399235 4134 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 60 None -18 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and GPR35-GA14-VP16 transcription factor fusion protein assessed as transcriptional activation after 5 hrs by tango beta-arrestin translocation reporter assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
660319 11003 96 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 11003 96 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
68324914 185731 38 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185731 38 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
13950957 157328 7 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 157328 7 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
15774808 77691 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
CHEMBL2089194 77691 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 283 3 3 4 2.8 O=C(O)c1cc2cc(O)c(O)cc2n1Cc1ccccc1 10.1021/ml300076u
145958495 162198 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 162198 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
70687104 77703 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
CHEMBL2089223 77703 0 None - 1 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 305 2 4 3 3.2 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cc(F)cc(F)c1 10.1021/ml300076u
70689180 77693 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
CHEMBL2089196 77693 0 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 311 4 3 5 2.6 O=C(Cn1c(C(=O)O)cc2cc(O)c(O)cc21)c1ccccc1 10.1021/ml300076u
145958495 162198 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 162198 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
10868388 162133 47 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 162133 47 None - 1 Human 4.4 pEC50 = 4.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145954149 162599 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162599 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
154634323 184604 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184604 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145954149 162599 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162599 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
15774807 77689 31 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 77689 31 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
53258898 68073 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 68073 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
70697498 77690 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 77690 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
21337669 68063 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 68063 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
145952561 162959 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 162959 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
70691268 77709 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
CHEMBL2089229 77709 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 364 1 2 3 4.1 Cc1c(C(=O)O)sc2cc(Br)c(O)c(Br)c12 10.1021/ml300076u
135403802 26531 56 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26531 56 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
3884 44498 77 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44498 77 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
154634328 185101 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 185101 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 186406 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186406 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
2920 2997 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
54742459 2997 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
8546 2997 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
CHEMBL177880 2997 103 None 3388 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.0c01624
6619478 25937 3 None -9 2 Human 6.3 pEC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 25937 3 None -9 2 Human 6.3 pEC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
70683937 75041 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
CHEMBL2035007 75041 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 408 1 1 3 5.2 O=C(O)c1sc2c(Br)c(Br)sc2c1C(F)(F)F 10.1016/j.bmcl.2012.04.057
145955027 162540 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 162540 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
145955027 162540 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 162540 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
5491415 75292 19 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 75292 19 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
44351698 120848 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 120848 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response measured for 60 mins by DMR assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
145958540 162270 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 162270 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
6622007 39042 7 None -9 4 Human 5.3 pEC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 39042 7 None -9 4 Human 5.3 pEC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
145958540 162270 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 162270 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
70683939 75306 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 75306 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70686065 75309 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037464 75309 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 264 2 2 4 3.4 Cc1c(C(=O)O)sc2c(-c3cn[nH]c3)csc12 10.1016/j.bmcl.2012.04.057
70690213 75313 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 75313 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
135399235 4134 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
2919 4134 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
5722 4134 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
CHEMBL28079 4134 60 None -18 3 Human 5.3 pEC50 = 5.3 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml300076u
21337671 68064 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 68064 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
153273978 195926 4 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 195926 4 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 195926 4 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
164627011 186406 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186406 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
70694439 75305 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037460 75305 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 222 1 1 3 3.0 C#Cc1csc2c(C)c(C(=O)O)sc12 10.1016/j.bmcl.2012.04.057
145971442 163027 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 163027 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145971442 163027 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 163027 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
5280343 188275 124 None -8 12 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 188275 124 None -8 12 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 188275 124 None -8 12 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
154634332 185127 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185127 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
16103465 68068 2 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 68068 2 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
16103462 68069 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 68069 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
145952912 162444 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 162444 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
135399235 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
70682869 77381 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
CHEMBL2086422 77381 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 275 2 4 4 3.0 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1ccsc1 10.1021/ml300076u
145954727 162421 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 162421 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952912 162444 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 162444 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
70684936 77708 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 77708 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
135399235 4134 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4134 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4134 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4134 60 None -18 3 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 185997 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185997 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 162421 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 162421 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
135399235 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
2919 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
5722 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
CHEMBL28079 4134 60 None -18 3 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1016/j.bmcl.2012.04.057
66561793 75311 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037466 75311 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 258 2 2 3 3.3 Cc1c(C(=O)O)[nH]c2c(-c3cccnc3)csc12 10.1016/j.bmcl.2012.04.057
16103462 68069 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 68069 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
16103462 68069 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 68069 19 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
15774807 77689 31 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089192 77689 31 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 207 1 3 4 1.3 Cn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
45489602 59275 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 59275 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
154634336 186068 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 186068 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
45489602 59275 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 59275 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
21337670 68060 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 68060 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
70686064 75300 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037454 75300 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 354 1 1 3 4.5 Cc1c(C(=O)O)sc2c(Br)c(Br)sc12 10.1016/j.bmcl.2012.04.057
44351698 120848 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
CHEMBL3558475 120848 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Agonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assayAgonist activity at human GPR35 receptor expressed in HEK293T cells co-expressing beta-arrestin2 assessed as induction of beta-arrestin2 recruitment by BRET assay
ChEMBL 464 8 3 7 3.2 O=C(O)c1cc(=O)c2c(CCC(O)CCc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 10.1021/acs.jmedchem.0c01624
5328791 204984 64 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 204984 64 None - 1 Human 4.2 pEC50 = 4.2 Functional
Agonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assayAgonist activity at GPR35 receptor in human U2OS cells coexpressing Gal4-VP16-TEV assessed as beta arrestin translocation after 5 hrs by beta lactamase reporter gene assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
1024 16488 106 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16488 106 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
5215 2386 132 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2386 132 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2386 132 None -1 4 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
20259231 77707 18 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
CHEMBL2089227 77707 18 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 210 1 3 4 2.0 O=C(O)c1cc2cc(O)c(O)cc2s1 10.1021/ml300076u
70689184 77700 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
CHEMBL2089220 77700 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 313 3 5 4 2.6 O=C(O)c1cccc(-c2c(C(=O)O)[nH]c3cc(O)c(O)cc23)c1 10.1021/ml300076u
70697498 77690 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
CHEMBL2089193 77690 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 221 2 3 4 1.8 CCn1c(C(=O)O)cc2cc(O)c(O)cc21 10.1021/ml300076u
326869 112811 5 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112811 5 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
164610101 184875 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184875 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
5280343 188275 124 None -8 12 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 188275 124 None -8 12 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 188275 124 None -8 12 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
154634314 186609 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186609 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145953203 162538 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 162538 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
16103462 68069 19 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL1914588 68069 19 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1016/j.bmcl.2012.04.057
145953203 162538 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 162538 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
70681839 75312 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037467 75312 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 221 2 2 2 3.1 Cc1c(C(=O)O)[nH]c2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70689183 77699 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
CHEMBL2089219 77699 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells measured after 10 mins by dynamic mass redistribution assay
ChEMBL 270 2 4 4 2.3 O=C(O)c1[nH]c2cc(O)c(O)cc2c1-c1cccnc1 10.1021/ml300076u
145952039 162808 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162808 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145952039 162808 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162808 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 163012 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 163012 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
151271218 186155 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 186155 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145959908 162062 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 162062 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 162788 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162788 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145959908 162062 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 162062 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
145952453 162788 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162788 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
145974046 163012 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 163012 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
70690213 75313 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037468 75313 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Agonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assayAgonist activity at GPR35 in human U20S cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay
ChEMBL 273 1 1 3 3.0 Cc1c(C(=O)O)n(C)c2c(Br)csc12 10.1016/j.bmcl.2012.04.057
70684936 77708 0 None - 1 Human 4.0 pEC50 = 4.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
CHEMBL2089228 77708 0 None - 1 Human 4.0 pEC50 = 4.0 Functional
Agonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assayAgonist activity at human GPR35 expressed in U2OS cells coexpressing Gal4-VP16/beta-arrestin fusion protein after 5 hrs by tango beta-arrestin translocation reporter gene assay
ChEMBL 224 1 3 4 2.3 Cc1c(C(=O)O)sc2cc(O)c(O)cc12 10.1021/ml300076u
154634335 184483 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 184483 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634316 186342 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 186342 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as dynamic mass redistribution response by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
53258899 68067 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 68067 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
57697 14466 38 None - 1 Rat 7.0 pEC50 = 7.0 Functional
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
CHEMBL1201198 14466 38 None - 1 Rat 7.0 pEC50 = 7.0 Functional
Agonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assayAgonist activity at recombinant rat N-terminal FLAG/eYFP-fused GPR35 expressed in HEK293 cells assessed as induction of beta-arrestin recruitment by BRET assay
ChEMBL 228 1 1 6 0.2 Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12 10.1021/acsmedchemlett.7b00510
70683939 75306 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
CHEMBL2037461 75306 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 238 2 1 3 3.8 Cc1c(C(=O)O)sc2c(C3CC3)csc12 10.1016/j.bmcl.2012.04.057
70683938 75302 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
CHEMBL2037457 75302 1 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells by dynamic mass redistribution assay
ChEMBL 200 1 2 4 2.4 O=C(O)c1sc2ccsc2c1O 10.1016/j.bmcl.2012.04.057
5328791 204984 64 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 204984 64 None - 1 Human 5.0 pEC50 = 5.0 Functional
Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assayAgonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
154634333 185215 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185215 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
326869 112811 5 None - 1 Human 9.1 pIC50 = 9.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112811 5 None - 1 Human 9.1 pIC50 = 9.1 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634333 185215 0 None - 1 Human 8.0 pIC50 = 8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185215 0 None - 1 Human 8.0 pIC50 = 8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
3110120 41918 10 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
CHEMBL1494365 41918 10 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 10 3 5 5.2 CCCCCOC(=O)c1ccc(NC(=O)c2cccc(NC(=O)c3ccccc3C(=O)O)c2)cc1 nan
644413 33531 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
CHEMBL1420573 33531 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 315 1 1 5 2.0 CN1C=CC2=C(C#N)C(N)C(C#N)(C#N)C(c3ccccc3)C2C1 nan
9581006 59388 2 None 12 3 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709028 59388 2 None 12 3 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 379 5 2 6 3.0 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccccc1 nan
18296 69862 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5351211 69862 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
5474842 69862 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
6326610 69862 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL193872 69862 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
CHEMBL466853 69862 4 None 6 2 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 379 4 0 3 6.1 CCN1/C(=C/C(C)=C/c2sc3ccccc3[n+]2CC)Sc2ccccc21 nan
152550147 185328 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 185328 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634315 184878 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852718 184878 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccc(F)cc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
53257379 68061 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
CHEMBL1914580 68061 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 363 1 0 4 5.0 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1Cl 10.1021/jm200999f
53258793 68070 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914589 68070 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 374 8 1 3 6.3 CCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
135399235 4134 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 60 None -18 3 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assayAntagonist activity at GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced DMR by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
151271218 186155 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 186155 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
4811966 43689 6 None 2 5 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
CHEMBL1510156 43689 6 None 2 5 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 4 1 4 3.3 CC(NC(=O)Cn1ncc(Cl)c(Cl)c1=O)C12CC3CC(CC(C3)C1)C2 nan
16103462 68069 19 None - 1 Human 7.0 pIC50 = 7.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914588 68069 19 None - 1 Human 7.0 pIC50 = 7.0 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
145957901 162075 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4160729 162075 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2ccc(Br)cc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145951357 162764 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4171772 162764 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 4.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1Cl 10.1021/acsmedchemlett.7b00510
5602180 55506 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1416442 55506 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
CHEMBL1620242 55506 5 None 1 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 334 1 1 2 4.1 CC1(C)Cc2c(ccc3ccccc23)/C(=C/C(=O)N2CCCCC2)N1 nan
16195500 41731 9 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1492565 41731 9 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C/c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 59546 4 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59546 4 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
150386356 185146 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 185146 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2963825 47702 10 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
CHEMBL1547464 47702 10 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 382 4 1 6 4.4 O=C(Nc1nc2ccccc2s1)c1ccc(N2CCCCC2)c([N+](=O)[O-])c1 nan
2259994 41406 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
CHEMBL1490312 41406 8 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 262 2 0 4 1.9 CN1C(=O)/C(=C\c2ccc(N(C)C)cc2)OC1=S nan
135549592 108442 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
CHEMBL3198952 108442 5 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 369 7 4 6 1.4 COc1ccc(/C=C\C(=O)NCC(=O)N/N=C/c2ccc(O)cc2O)cc1 nan
1416931 23418 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 23418 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
1348328 31786 7 None 16 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1406190 31786 7 None 16 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C/C=C/c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
5334489 45964 7 None 10 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1532412 45964 7 None 10 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 7 1 4 5.3 CCN(CC)c1ccc(/C=C(/C#N)c2nc3ccccc3[nH]2)c(OC(C)C)c1 nan
4137407 29812 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1387336 29812 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 3 1 7 4.6 Cc1nc(N2CCC(C)CC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
152684818 184992 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 184992 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
5733585 40970 10 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 40970 10 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
655684 41089 8 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
CHEMBL1487918 41089 8 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 383 1 1 5 3.3 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3cccc(Cl)c3Cl)C2C1 nan
9990345 68065 35 None - 1 Human 4.9 pIC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
CHEMBL1914584 68065 35 None - 1 Human 4.9 pIC50 = 4.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 199 0 0 4 1.9 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)C 10.1021/jm200999f
135399235 4134 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
2919 4134 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
5722 4134 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
CHEMBL28079 4134 60 None -18 3 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm200999f
6484583 37236 4 None -89 3 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
CHEMBL1453578 37236 4 None -89 3 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]
ChEMBL 410 5 1 5 2.6 COc1ccc(S(=O)(=O)N2CCOCC2)cc1NC(=O)c1ccc(Cl)cc1 nan
9581013 59710 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 59710 4 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
1348329 26248 12 None 3 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 26248 12 None 3 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
145952561 162959 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4174783 162959 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(C(F)(F)F)c1 10.1021/acsmedchemlett.7b00510
13950957 157328 7 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 157328 7 None - 1 Human 6.9 pIC50 = 6.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2961024 44931 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
CHEMBL1523126 44931 6 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 452 8 2 4 5.7 CCOc1ccc(NC(=O)C(C)Oc2ccccc2C(=O)Nc2ccc(C)c(Cl)c2)cc1 nan
149708825 186391 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 186391 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24792210 55191 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1351967 55191 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1617564 55191 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 391 5 1 4 5.0 CN(C)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
145953959 162677 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4170205 162677 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 411 3 2 4 3.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(C(F)(F)F)cc1 10.1021/acsmedchemlett.7b00510
72652 34848 62 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
CHEMBL1431610 34848 62 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 309 0 0 3 3.5 O=c1cc(C(F)(F)F)c2cc3c4c(c2o1)CCCN4CCC3 nan
151577785 186553 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 186553 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
135475176 108024 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
135517099 108024 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
CHEMBL3194571 108024 9 None - 1 Human 4.9 pIC50 = 4.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 2 1 4 5.1 CC12CCC(C/C1=N\NC1=NC(=O)/C(=C\c3ccc(Cl)cc3)S1)C2(C)C nan
2745687 933 31 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 933 31 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 933 31 None 10 3 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
1346721 29819 11 None 1 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
CHEMBL1387413 29819 11 None 1 2 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 440 7 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1 nan
145956623 162013 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4159575 162013 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 391 4 2 5 3.0 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c(F)c1 10.1021/acsmedchemlett.7b00510
3153499 32576 18 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
CHEMBL1412529 32576 18 None - 1 Human 5.9 pIC50 = 5.9 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 344 3 0 5 2.5 CS(=O)(=O)N1N=C(c2ccccc2)CC1c1ccc2c(c1)OCO2 nan
16196320 55059 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
3394229 55059 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
5813410 55059 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1308547 55059 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
CHEMBL1616589 55059 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 3 0 3 4.4 CC1=CC(=Cc2sc3ccccc3[n+]2C)C=C(C)N1CC1CCCO1 nan
1382708 29864 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 29864 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
4362054 26091 7 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1355774 26091 7 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 495 9 2 8 4.3 CCOc1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
152727536 184487 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 184487 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
24761764 52813 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
CHEMBL1595152 52813 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 387 5 1 3 4.3 CC(NS(=O)(=O)OCC(Cl)(Cl)Cl)c1ccc(C(C)(C)C)cc1 nan
16103482 68066 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
CHEMBL1914585 68066 1 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1c(C(=O)O)sc2ccsc12 10.1021/jm200999f
6518655 108807 7 None 2 3 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
CHEMBL3209511 108807 7 None 2 3 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 528 7 1 7 5.5 COc1ccc(/N=C2\S/C(=C\c3ccc(N4CCOCC4)o3)C(=O)N2CCc2c[nH]c3ccccc23)cc1 nan
154634327 184739 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184739 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
154634324 185711 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185711 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164627011 186406 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186406 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
154634326 185092 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185092 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
150386356 185146 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856916 185146 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
1382708 29864 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1387749 29864 11 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.6 O=C(CCCN1C(=O)S/C(=C/c2ccccc2)C1=S)Nc1ccc(C(=O)O)cc1 nan
2885134 44439 8 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
CHEMBL1518827 44439 8 None - 1 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 373 6 2 5 5.0 CCOc1ccc2nc3cc(NCc4ccc(OC)cc4)ccc3c(N)c2c1 nan
45917986 59355 7 None -6 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
CHEMBL1707517 59355 7 None -6 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 314 2 0 4 4.4 Cc1ccc(-c2nnc(C)c3nn(-c4ccc(C)cc4)cc23)cc1 nan
2286888 41080 10 None 11 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
CHEMBL1487870 41080 10 None 11 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 466 8 2 5 5.0 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)cc2)C1=O)=C\c1ccccc1 nan
2247463 27593 9 None 15 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
CHEMBL1369492 27593 9 None 15 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 515 8 3 7 4.6 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(C(C)C)cc3)cc2)s1 nan
154634328 185101 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 185101 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
152727536 184487 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4847144 184487 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 288 2 2 5 2.9 O=C(O)c1cc2cc(-c3cccs3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
145954149 162599 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4169062 162599 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1 10.1021/acsmedchemlett.7b00510
2745687 933 31 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
9741 933 31 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
CHEMBL1708510 933 31 None 10 3 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F nan
8072340 55842 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1517609 55842 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
CHEMBL1623159 55842 6 None -1 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 263 2 1 0 3.8 Cc1ccc2[nH]c(C)c(/C=C/c3cc[n+](C)cc3)c2c1 nan
1205881 36165 5 None 23 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 36165 5 None 23 2 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
21337669 68063 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
CHEMBL1914582 68063 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 239 0 0 4 2.9 CC1=C(C#N)C(=C(C#N)C#N)OC12CCCCC2 10.1021/jm200999f
1231538 27518 29 None -1 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 27518 29 None -1 3 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
3596034 42329 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1498210 42329 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 308 2 0 4 3.0 CCN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
9581010 59180 4 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 59180 4 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
154634337 185333 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 185333 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
145971743 163104 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4177096 163104 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1F 10.1021/acsmedchemlett.7b00510
9581010 59180 4 None - 1 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1700467 59180 4 None - 1 Human 6.8 pIC50 = 6.8 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 449 5 2 6 3.9 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
152684818 184992 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
CHEMBL4854346 184992 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 312 3 2 5 2.9 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2cc1O 10.1021/acs.jmedchem.0c01624
21157241 71881 5 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
CHEMBL1970711 71881 5 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 381 5 1 5 2.3 COc1ccc(/C=c2\s/c(=C/C(=O)c3ccc(C)cc3)[nH]c2=O)c(OC)c1 nan
1502520 34501 21 None -9 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 34501 21 None -9 2 Human 4.8 pIC50 = 4.8 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
15945506 48021 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
CHEMBL1550295 48021 6 None - 1 Human 5.8 pIC50 = 5.8 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 5 1 4 5.8 CC(=O)c1ccc(NC(=O)C(C)n2nc(-c3ccccc3)c3cc(Cl)ccc32)cc1 nan
154634326 185092 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185092 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634321 185997 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185997 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
152243845 184899 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 184899 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
2770749 56029 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5708223 56029 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
5830170 56029 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1572785 56029 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
CHEMBL1624721 56029 4 None 1 3 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 281 4 0 1 3.9 CN(C)/C=C/C=C/C=C/C1=[N+](C)c2ccccc2C1(C)C nan
53258796 68072 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914591 68072 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 444 13 1 3 8.3 CCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
2277094 49016 10 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 49016 10 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
11674067 68059 28 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
CHEMBL1914578 68059 28 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 315 1 0 4 3.6 CC1=C(C#N)C(=C(C#N)C#N)OC1(c1ccccc1)C(F)(F)F 10.1021/jm200999f
2526579 54767 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
CHEMBL1612267 54767 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 423 12 1 7 5.0 CCN(CC)CCCNc1ccc(-c2nnc(-c3ccc(OCC(C)C)cc3)o2)cn1 nan
6489901 56163 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1576905 56163 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
CHEMBL1626041 56163 4 None 1 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 289 4 0 1 4.1 C=CCn1c(C)c(/C=C/c2cc[n+](C)cc2)c2ccccc21 nan
326869 112811 5 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112811 5 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634321 185997 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185997 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634332 185127 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185127 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
68324914 185731 38 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185731 38 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
154634328 185101 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856069 185101 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 378 3 2 6 3.0 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958495 162198 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
CHEMBL4162653 162198 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 4 3.1 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)C1CCCCC1 10.1021/acsmedchemlett.7b00510
150149078 186344 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 186344 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
5144920 21348 3 None 1 2 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
CHEMBL1314099 21348 3 None 1 2 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 424 3 1 7 4.3 Cc1c(C(=O)Nc2ccc3c(c2)OCCO3)sc2ncnc(N3CCC(C)CC3)c12 nan
4557537 38098 4 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
CHEMBL1460894 38098 4 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 424 3 1 7 4.3 Cc1nc(N2CCCCC2)c2c(C)c(C(=O)Nc3ccc4c(c3)OCCO4)sc2n1 nan
6203183 52352 8 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1589711 52352 8 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 486 7 3 8 3.4 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
6876400 72989 5 None 3 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
CHEMBL2007593 72989 5 None 3 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 8 2 6 5.0 CCOc1ccc(/C=N/NC(=O)Cc2csc(Nc3cccc(C(F)(F)F)c3)n2)cc1 nan
154634324 185711 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4865638 185711 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 384 3 2 7 3.0 O=C(O)c1cc2c(oc1=O)c(-c1cccs1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145958540 162270 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4163894 162270 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(Cl)cc1 10.1021/acsmedchemlett.7b00510
145952912 162444 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4166473 162444 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 361 3 2 4 3.0 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(F)c1 10.1021/acsmedchemlett.7b00510
9581015 59399 4 None - 1 Human 6.7 pIC50 = 6.7 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 59399 4 None - 1 Human 6.7 pIC50 = 6.7 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
3243122 46404 7 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
CHEMBL1536710 46404 7 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 421 3 0 5 4.6 COc1ccc2nc3oc(C(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3cc2c1 nan
5731274 52350 9 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
CHEMBL1589694 52350 9 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 468 8 1 6 4.8 CCOC(=O)c1ccc(NC(=O)CCCN2C(=O)/C(=C/c3ccc(C)cc3)SC2=S)cc1 nan
21337670 68060 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
CHEMBL1914579 68060 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 321 0 0 4 4.1 CC1=C(C#N)C(=C(C#N)C#N)OC12c1ccccc1-c1ccccc12 10.1021/jm200999f
8108341 37629 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
CHEMBL1457048 37629 6 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 364 7 1 3 5.1 O=C(O)COc1ccc(/C=C/C(=O)c2ccc(C3CCCCC3)cc2)cc1 nan
720233 50191 39 None 2 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
CHEMBL1570760 50191 39 None 2 2 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 288 2 0 3 3.3 O=c1c(Cl)c(Cl)cnn1Cc1ccccc1Cl nan
9581015 59399 4 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1709632 59399 4 None - 1 Human 4.7 pIC50 = 4.7 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(=S)Nc1ccccc1 nan
154634314 186609 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186609 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
3420390 178610 5 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
CHEMBL467373 178610 5 None - 1 Human 5.7 pIC50 = 5.7 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 474 8 2 5 1.6 NS(=O)(=O)c1ccc(CCNC(=O)CCS(=O)(=O)c2ccc(Br)cc2)cc1 nan
151577785 186553 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4878047 186553 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 312 3 2 5 2.9 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)c1 10.1021/acs.jmedchem.0c01624
5513575 42727 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
CHEMBL1501743 42727 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 4 2 5 4.9 N=C1/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)C(=O)N=C2SC=C(c3ccccc3)N12 nan
9581008 59546 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59546 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
4623233 60047 7 None -12 3 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
CHEMBL1736438 60047 7 None -12 3 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 320 2 0 4 4.4 Cc1nnc(-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12 nan
16193843 46079 6 None - 1 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
CHEMBL1533415 46079 6 None - 1 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 3 1 7 3.8 CC(C)CSC1=NSC2=NC(=O)/C(=C\c3coc4ccccc4c3=O)C(=N)N12 nan
2286812 29466 35 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
CHEMBL1384502 29466 35 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 nan
5768597 20771 6 None 3 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
CHEMBL1309475 20771 6 None 3 2 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 320 3 1 5 3.1 N#C/C(=C/c1ccc(N2CCOCC2)o1)c1nc2ccccc2[nH]1 nan
12005127 44806 4 None -3 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
CHEMBL1521989 44806 4 None -3 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 333 6 0 4 4.6 COc1cc(/C=C(/C)[N+](=O)[O-])ccc1OCc1ccccc1Cl nan
9581008 59546 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
CHEMBL1716874 59546 4 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 353 4 2 6 1.4 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(F)cc1F nan
154634318 185999 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 185999 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
164627011 186406 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186406 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1346847 21201 8 None - 1 Human 6.6 pIC50 = 6.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 21201 8 None - 1 Human 6.6 pIC50 = 6.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
154634322 185380 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 185380 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
6109309 29981 3 None 3 3 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
CHEMBL1388639 29981 3 None 3 3 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 355 5 1 4 4.0 CC(NC(=O)/C(C#N)=C/c1ccc(Cl)c([N+](=O)[O-])c1)c1ccccc1 nan
6622007 39042 7 None -9 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
CHEMBL1468612 39042 7 None -9 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 489 3 2 7 4.6 CC(C)(C)OC(=O)N1CCC(c2cc(O)n3ncc(C(=O)Nc4ccc(F)c(Cl)c4)c3n2)CC1 nan
4798059 31925 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
CHEMBL1407436 31925 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 296 4 1 3 4.3 COc1ccc2nc(C)cc(NCc3ccc(F)cc3)c2c1 nan
154634335 184483 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 184483 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
154634323 184604 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184604 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145971442 163027 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4175848 163027 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
145953203 162538 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
CHEMBL4167991 162538 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 403 5 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1OC 10.1021/acsmedchemlett.7b00510
145955027 162540 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
CHEMBL4168042 162540 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 349 3 2 5 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccs1 10.1021/acsmedchemlett.7b00510
6226024 45669 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
CHEMBL1529781 45669 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 442 7 3 6 3.7 O=C(CCCN1C(=O)/C(=C/c2ccccc2)SC1=S)Nc1ccc(C(=O)O)c(O)c1 nan
154634336 186068 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 186068 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 186342 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 186342 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
759209 35971 10 None -1 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
CHEMBL1442788 35971 10 None -1 4 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 259 1 0 3 3.5 Cc1c(Cl)sn(-c2ccc(Cl)cc2)c1=O nan
648447 38800 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
CHEMBL1466582 38800 7 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 3 1 7 2.1 COc1cccc(C2C3CN(C)CC=C3C(C#N)=C(N)C2(C#N)C#N)c1OC nan
1527596 43088 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
CHEMBL1504949 43088 10 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 448 7 2 7 4.9 CCOC(=O)c1c(-c2ccccc2)csc1NC(=O)/C(C#N)=C/c1ccc(O)c(OC)c1 nan
4406525 38434 5 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
CHEMBL1463795 38434 5 None - 1 Human 5.6 pIC50 = 5.6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 294 1 0 4 2.6 CN1CCN(C2=CC3=CC(=C(C#N)C#N)CCC3CC2)CC1 nan
45489602 59275 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL1704189 59275 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccccc2-c2nn[nH]n2)cc1 10.1021/acsmedchemlett.7b00510
145971240 163087 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4176719 163087 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 309 3 2 4 2.2 CC(C)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
164610101 184875 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184875 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1214651 59574 9 None -42 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
CHEMBL1718220 59574 9 None -42 4 Human 4.6 pIC50 = 4.6 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 414 2 0 4 5.7 Cc1nnc(-c2cccc3ccccc23)c2cn(-c3cccc(Br)c3)nc12 nan
154634327 184739 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184739 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
6619478 25937 3 None -9 2 Human 4.5 pIC50 = 4.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
CHEMBL1354041 25937 3 None -9 2 Human 4.5 pIC50 = 4.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 501 4 2 8 4.5 COc1ccc(NC(=O)c2cnn3c(O)cc(C4CCN(C(=O)OC(C)(C)C)CC4)nc23)cc1Cl nan
154634337 185333 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4859764 185333 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
164627011 186406 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
CHEMBL4876009 186406 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 350 2 2 4 3.8 Cc1c2nc(C(=O)O)cc(Cl)c2cc2c(Cl)cc(C(=O)O)nc12 10.1021/acs.jmedchem.0c01624
1024 16488 106 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16488 106 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634320 186610 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186610 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634331 184548 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 184548 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145952453 162788 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
CHEMBL4172188 162788 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 343 3 2 4 2.9 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1 10.1021/acsmedchemlett.7b00510
14286542 72220 3 None -4 4 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
CHEMBL1981103 72220 3 None -4 4 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 401 2 3 4 2.9 CC1=CC2/C=C(\C)CCC(O)C(O)/C=C/C(=O)C23C(=O)NC(CC(C)C)C3C1C nan
9581005 59631 2 None 21 2 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
CHEMBL1720530 59631 2 None 21 2 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 359 4 2 6 2.3 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)NC(C)(C)C nan
135650717 108212 5 None -2 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
CHEMBL3196703 108212 5 None -2 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 374 4 3 6 4.3 Oc1ccc(/C=N/Nc2nc(-c3ccccc3F)nc3ccccc23)c(O)c1 nan
6226345 31145 8 None 4 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
CHEMBL1400236 31145 8 None 4 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 353 5 3 4 2.9 CCCCN1C(=O)NC(=O)/C(=C(O)\C=C\c2c[nH]c3ccccc23)C1=O nan
2868490 54317 11 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
CHEMBL1608333 54317 11 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 3 0 3 5.6 COc1ccc(C=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)cc1OC nan
9581007 59270 2 None - 1 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
CHEMBL1704074 59270 2 None - 1 Human 6.5 pIC50 = 6.5 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 413 5 2 6 3.6 COC(=O)c1cnn(-c2ccccc2)c1/C=N/NC(=S)Nc1ccc(Cl)cc1 nan
16437205 32003 9 None -2 3 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
CHEMBL1407961 32003 9 None -2 3 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 6 1 7 2.7 CCC1CCCCN1S(=O)(=O)c1ccc(NC(=O)c2nc(S(C)(=O)=O)ncc2Cl)cc1 nan
1416931 23418 6 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1333032 23418 6 None - 1 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1ccc(C(=O)O)cc1 nan
150149078 186344 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875041 186344 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 282 2 2 4 2.9 O=C(O)c1cc2cc(-c3ccccc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
12533774 185518 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 185518 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634316 186342 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4875009 186342 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 426 4 2 7 3.1 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)c(F)c1 10.1021/acs.jmedchem.0c01624
24792182 55084 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1306983 55084 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
CHEMBL1616747 55084 0 None -1 2 Human 5.5 pIC50 = 5.5 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 417 6 1 5 5.2 COc1ccc(C)cc1Nc1n[n+](-c2ccccc2)c(-c2ccc(N(C)C)cc2)s1 nan
57134579 162632 18 None - 1 Human 4.5 pIC50 = 4.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4169520 162632 18 None - 1 Human 4.5 pIC50 = 4.5 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145974046 163012 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4175617 163012 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
13950957 157328 7 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4077503 157328 7 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
9581012 59588 4 None - 1 Human 6.4 pIC50 = 6.4 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
CHEMBL1718866 59588 4 None - 1 Human 6.4 pIC50 = 6.4 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 415 5 2 6 3.3 COC(=O)c1cnn(-c2ccc(F)cc2F)c1/C=N/NC(=S)Nc1ccccc1 nan
6393553 47086 6 None 5 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
CHEMBL1542492 47086 6 None 5 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 311 5 1 5 3.0 CC(NC(=O)/C(C#N)=C/c1ccc([N+](=O)[O-])o1)c1ccccc1 nan
145952039 162808 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4172440 162808 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
2269231 45920 10 None 13 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 45920 10 None 13 2 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
145959908 162062 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
CHEMBL4160515 162062 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccccc1Cl 10.1021/acsmedchemlett.7b00510
9581013 59710 4 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
CHEMBL1723578 59710 4 None - 1 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 351 4 2 6 1.7 CNC(=S)N/N=C/c1c(C(=O)OC)cnn1-c1ccc(Cl)cc1 nan
12533774 185518 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4862654 185518 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 316 2 2 6 1.6 Cc1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
2841621 27700 7 None 2 3 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
CHEMBL1370183 27700 7 None 2 3 Human 5.4 pIC50 = 5.4 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 354 4 0 4 3.8 CCOC(=O)C1=C(Cc2ccc(Cl)cc2)C(=O)c2ccccc2C1=O nan
154634320 186610 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4879017 186610 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 302 2 2 6 1.3 O=C(O)c1cc2c(ccc3cc(C(=O)O)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
154634334 185425 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 185425 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145950576 162879 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
CHEMBL4173352 162879 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 333 3 2 5 2.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccco1 10.1021/acsmedchemlett.7b00510
56646802 68058 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
CHEMBL1914577 68058 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 351 1 0 4 3.8 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1c(F)c(F)c(F)c(F)c1F 10.1021/jm200999f
5346366 41498 6 None 2 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1490915 41498 6 None 2 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
154634333 185215 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4857772 185215 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 352 2 2 6 2.4 O=C(O)c1cc2c3ccccc3c3cc(C(=O)O)c(=O)oc3c2oc1=O 10.1021/acs.jmedchem.0c01624
9581014 59996 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
CHEMBL1734603 59996 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 5. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]
ChEMBL 337 4 2 6 1.5 COC(=O)c1cnn(-c2ccc(Cl)cc2)c1/C=N/NC(N)=S nan
53258899 68067 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914586 68067 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 268 6 1 3 4.8 CCCCCCc1csc2cc(C(=O)O)sc12 10.1021/jm200999f
152243845 184899 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4853043 184899 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 324 3 2 4 4.0 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3cc2O)cc1 10.1021/acs.jmedchem.0c01624
154634332 185127 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185127 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634330 185952 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 185952 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
1214658 59473 9 None -4 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
CHEMBL1713756 59473 9 None -4 3 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 6. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 392 4 0 5 5.5 COc1ccc(-n2cc3c(-c4ccc(-c5ccccc5)cc4)nnc(C)c3n2)cc1 nan
135399235 4134 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
2919 4134 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
5722 4134 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
CHEMBL28079 4134 60 None -18 3 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.0c01624
154634321 185997 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4870213 185997 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
154634336 186068 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4871203 186068 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1c2oc(=O)c(C(=O)O)cc2cc2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634314 186609 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4878979 186609 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
145955278 162559 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4168406 162559 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 377 3 2 4 3.5 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1cccc(Cl)c1 10.1021/acsmedchemlett.7b00510
21337671 68064 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
CHEMBL1914583 68064 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 297 1 0 4 3.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(F)cc1F 10.1021/jm200999f
68324914 185731 38 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
CHEMBL4865971 185731 38 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 284 2 2 5 3.6 O=C(O)c1cc2sc3cc(C(=O)O)sc3c2s1 10.1021/acs.jmedchem.0c01624
7424594 52989 4 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
CHEMBL1596753 52989 4 None - 1 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 375 5 1 3 5.3 O=C(/C=C/c1ccco1)c1ccc(NC(=O)C23CC4CC(CC(C4)C2)C3)cc1 nan
145959592 162350 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4164993 162350 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
6202912 48209 8 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
CHEMBL1552304 48209 8 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 502 9 3 8 3.7 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)c(O)c3)C2=O)cc1OC nan
1477048 29734 19 None 23 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
CHEMBL1386711 29734 19 None 23 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 438 5 0 5 4.3 CN(C)/C=C/C(=O)c1ccc(N2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)cc1 nan
5936070 34053 9 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
CHEMBL1424929 34053 9 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 427 4 1 4 6.4 CC(=O)Nc1sc(/C(C#N)=C/c2ccc(Cl)c(Cl)c2)nc1-c1ccc(C)cc1 nan
154634323 184604 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4848949 184604 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
151271218 186155 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4872368 186155 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccc(F)cc3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
1609318 42631 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
CHEMBL1500763 42631 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 297 12 2 4 3.4 C=CCCCCCCCCc1nc(SCC(=O)O)n[nH]1 nan
282594 45347 17 None -2 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
CHEMBL1526855 45347 17 None -2 5 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 331 2 0 3 3.7 CC(=O)N(C1=C(Cl)C(=O)c2ccccc2C1=O)C1CCCCC1 nan
5334290 25923 10 None 7 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
CHEMBL1353925 25923 10 None 7 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 7 1 4 5.6 CCN(CC)c1ccc(/C=C(/C#N)c2nc3cc(C)ccc3[nH]2)c(OC(C)C)c1 nan
4189659 28053 5 None 6 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 28053 5 None 6 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
2269231 45920 10 None 13 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1532025 45920 10 None 13 2 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1ccc(C(=O)O)cc1 nan
5733585 40970 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
CHEMBL1487024 40970 10 None - 1 Human 6.3 pIC50 = 6.3 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 486 9 2 7 4.0 COc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3cccc(C(=O)O)c3)C2=O)cc1OC nan
4189659 28053 5 None 6 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
CHEMBL1372770 28053 5 None 6 2 Human 5.3 pIC50 = 5.3 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 493 8 2 7 5.1 CC(C)c1ccc(NC(=O)CSc2nc3ccsc3c(=O)n2Cc2ccc(C(=O)O)cc2)cc1 nan
53258795 68071 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914590 68071 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 416 11 1 3 7.5 CCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
660319 11003 96 None - 1 Human 4.2 pIC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
CHEMBL1173787 11003 96 None - 1 Human 4.2 pIC50 = 4.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 184 1 1 3 2.7 O=C(O)c1cc2sccc2s1 10.1021/jm200999f
5722655 20110 6 None 17 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
CHEMBL1304179 20110 6 None 17 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 388 8 1 4 5.6 CCCOc1cc(N(CC)CC)ccc1/C=C(/C#N)c1nc2cc(C)ccc2[nH]1 nan
1024 16488 106 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
CHEMBL1235421 16488 106 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acs.jmedchem.0c01624
154634318 185999 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4870255 185999 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 318 2 3 7 1.0 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(O)c2oc1=O 10.1021/acs.jmedchem.0c01624
53258898 68073 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
CHEMBL1914592 68073 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 472 15 1 3 9.1 CCCCCCCCCCCCCCCc1c(C(=O)O)sc2c(Br)csc12 10.1021/jm200999f
154634334 185425 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4861414 185425 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1ccccc1F)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
154634330 185952 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4869539 185952 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 396 3 2 6 3.1 O=C(O)c1cc2c(oc1=O)c(-c1cccc(F)c1)cc1cc(C(=O)O)c(=O)oc12 10.1021/acs.jmedchem.0c01624
164610101 184875 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184875 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
12138435 68057 29 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
CHEMBL1914576 68057 29 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm200999f
145951566 162765 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
CHEMBL4171782 162765 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 379 3 2 4 3.2 O=C(Nc1cc(Br)ccc1-c1nnn[nH]1)c1ccc(F)cc1F 10.1021/acsmedchemlett.7b00510
16103465 68068 2 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
CHEMBL1914587 68068 2 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 254 1 1 4 4.2 Cc1csc2c1sc1cc(C(=O)O)sc12 10.1021/jm200999f
11957284 35936 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
CHEMBL1442537 35936 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 441 3 2 8 5.0 Cc1nnc(NC(=O)c2sc3nc(-c4cccs4)cc(C(F)(F)F)c3c2N)s1 nan
1542103 22484 24 None 2 3 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
CHEMBL1325250 22484 24 None 2 3 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 418 4 0 6 4.2 Cc1ccccc1N1CCN(c2ncnc3c2cnn3Cc2ccc(Cl)cc2)CC1 nan
154634335 184483 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
CHEMBL4847100 184483 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 408 4 2 7 3.0 COc1cccc(-c2c3oc(=O)c(C(=O)O)cc3cc3cc(C(=O)O)c(=O)oc23)c1 10.1021/acs.jmedchem.0c01624
20992 197072 77 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
CHEMBL567422 197072 77 None 1 3 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 276 7 0 4 0.4 O=C1C=CC(=O)N1CCCCCCN1C(=O)C=CC1=O nan
24789826 55065 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1307717 55065 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
CHEMBL1616626 55065 0 None 56 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 419 7 1 4 5.8 CCN(CC)c1ccc(-c2sc(Nc3ccccc3)n[n+]2-c2ccc(F)cc2)cc1 nan
1985027 32717 10 None 27 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
CHEMBL1413629 32717 10 None 27 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 454 8 2 5 4.6 CCc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)cc1 nan
12138434 68062 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
CHEMBL1914581 68062 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
Agonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assayAgonist activity at GPR35 in human HT-29 cells assessed as desensitization of 1 uM zaprinast-induced DMR after 1 hr by dynamic mass redistribution assay
ChEMBL 317 4 0 4 4.4 CCCCc1ccc(C2(C)OC(=C(C#N)C#N)C(C#N)=C2C)cc1 10.1021/jm200999f
164610101 184875 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
CHEMBL4852667 184875 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 342 4 2 6 2.5 COc1cc(C(=O)O)nc2c(C)c3nc(C(=O)O)cc(OC)c3cc12 10.1021/acs.jmedchem.0c01624
1803281 20065 8 None 15 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
CHEMBL1303807 20065 8 None 15 2 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 337 4 1 3 3.0 CN(C)c1ccc(/C=C2\NC(=S)N(Cc3ccccc3)C2=O)cc1 nan
798024 35424 5 None - 1 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
CHEMBL1437947 35424 5 None - 1 Human 5.2 pIC50 = 5.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 245 3 1 4 1.7 N#C/C(=C\c1ccc(N2CCCCC2)o1)C(N)=O nan
6201879 27388 16 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
CHEMBL1367928 27388 16 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 456 8 2 6 4.0 COc1cccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(C(=O)O)cc3)C2=O)c1 nan
154634332 185127 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4856506 185127 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 408 4 2 7 3.0 COc1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
145954727 162421 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4166100 162421 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 3 2 4 2.0 CCC(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
5767616 19599 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
CHEMBL1300169 19599 5 None - 1 Human 6.2 pIC50 = 6.2 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 370 5 1 5 4.3 CCOc1ccc(N(C)c2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1 nan
152550147 185328 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4859675 185328 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3cccc(F)c3)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
154634322 185380 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4860550 185380 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 307 1 1 8 1.0 N#Cc1cc2c(ccc3cc(-c4nnn[nH]4)c(=O)oc32)oc1=O 10.1021/acs.jmedchem.0c01624
1346847 21201 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
CHEMBL1312928 21201 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 412 6 2 5 4.3 Cc1ccc(/C=C2\SC(=S)N(CCCC(=O)Nc3ccc(O)cc3)C2=O)cc1 nan
10868388 162133 47 None - 1 Human 4.1 pIC50 = 4.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161599 162133 47 None - 1 Human 4.1 pIC50 = 4.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 239 1 2 4 1.2 Nc1ccc(Br)cc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
1502520 34501 21 None -9 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
CHEMBL1428840 34501 21 None -9 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 398 4 0 6 3.8 Cc1ccc(Cn2ncc3c(N4CCN(c5ccccc5C)CC4)ncnc32)cc1 nan
3860640 149831 47 None -13 3 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
CHEMBL394883 149831 47 None -13 3 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]PUBCHEM_BIOASSAY: SAR analysis of Antagonists of the GPR35 Receptor using an Image-Based Assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]
ChEMBL 331 2 3 3 3.7 Cc1cccc2c1NC(=O)C2(c1ccc(O)cc1)c1ccc(O)cc1 nan
1231538 27518 29 None -1 3 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
CHEMBL1368962 27518 29 None -1 3 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 nan
4559736 34673 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
CHEMBL1430125 34673 3 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 254 2 2 4 2.7 Nc1[nH]c2cc([N+](=O)[O-])ccc2c1-c1ccccn1 nan
326869 112811 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
CHEMBL3306990 112811 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acs.jmedchem.0c01624
154634331 184548 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
CHEMBL4848109 184548 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 420 4 2 6 4.1 CC(C)c1ccc(-c2cc3cc(C(=O)O)c(=O)oc3c3cc(C(=O)O)c(=O)oc23)cc1 10.1021/acs.jmedchem.0c01624
149708825 186391 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4875771 186391 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 300 2 2 4 3.0 O=C(O)c1cc2cc(-c3ccccc3F)c(O)cc2oc1=O 10.1021/acs.jmedchem.0c01624
2277094 49016 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1560901 49016 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 470 7 2 7 3.7 O=C(CCCN1C(=O)/C(=C/c2ccc3c(c2)OCO3)SC1=S)Nc1cccc(C(=O)O)c1 nan
1205881 36165 5 None 23 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
CHEMBL1444708 36165 5 None 23 2 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 426 7 2 5 4.0 O=C(CCCN1C(=O)/C(=C\c2ccccc2)SC1=S)Nc1cccc(C(=O)O)c1 nan
145958445 162131 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
CHEMBL4161574 162131 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 357 3 2 4 3.2 Cc1ccccc1C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1 10.1021/acsmedchemlett.7b00510
145959306 162315 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
CHEMBL4164556 162315 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 373 4 2 5 2.9 COc1cccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)c1 10.1021/acsmedchemlett.7b00510
145949189 162737 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4171326 162737 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 313 4 2 5 2.3 COc1ccc(C(=O)Nc2cc(F)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.7b00510
154634326 185092 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
CHEMBL4856029 185092 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Agonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assayAgonist activity at human GPR35 receptor expressed in HT-29 cells assessed as reduction in dynamic mass redistribution response in presence of GPR35 antagonist ML-145 by DMR assay
ChEMBL 404 2 2 8 1.5 O=C(O)c1cc2c(oc1=O)c(Br)cc1cc(-c3nnn[nH]3)c(=O)oc12 10.1021/acs.jmedchem.0c01624
2732121 38528 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
CHEMBL1464544 38528 5 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 306 3 0 4 3.6 CC(C)c1ccc(N2C(=O)/C(=C/N(C)C)SC2=S)cc1 nan
110720191 162457 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
CHEMBL4166802 162457 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Desensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulationDesensitization of GPR35 in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution pretreated for 1 hr followed by zaprinast stimulation
ChEMBL 295 4 2 5 2.1 COc1ccc(C(=O)Nc2ccc(-c3nnn[nH]3)cc2)cc1 10.1021/acsmedchemlett.7b00510
3276705 46393 9 None - 1 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
CHEMBL1536628 46393 9 None - 1 Human 5.1 pIC50 = 5.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 521 8 2 6 4.3 CCN(CC)S(=O)(=O)c1ccc(NC(=O)c2cccnc2Cl)c(NC(=O)c2cccnc2Cl)c1 nan
6974996 72019 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
CHEMBL1975147 72019 8 None - 1 Human 6.1 pIC50 = 6.1 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 389 6 0 6 3.6 CC/N=C1\S/C(=C\c2cc(OC)c(N3CCCC3)cc2OC)C(=O)N1CC nan
154634327 184739 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
CHEMBL4850743 184739 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Agonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assayAgonist activity at human GPR35 receptor expressed in CHO-K1 cells assessed as desensitization of zaprinast-induced DMR response preincubated for 1 hr followed by zaprinast stimulation by DMR desensitization assay
ChEMBL 380 2 2 6 2.1 O=C(O)c1cc2cc3cc(C(=O)O)c(=O)oc3c(Br)c2oc1=O 10.1021/acs.jmedchem.0c01624
18158890 23518 3 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 23518 3 None - 1 Human 6.0 pIC50 = 6.0 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
1348329 26248 12 None 3 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
CHEMBL1357976 26248 12 None 3 2 Human 5.0 pIC50 = 5.0 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 436 8 2 5 4.4 O=C(CCCN1C(=O)S/C(=C\C=C\c2ccccc2)C1=O)Nc1ccc(C(=O)O)cc1 nan
3804843 42246 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
CHEMBL1497386 42246 7 None - 1 Human 6.0 pIC50 = 6 Functional
PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]PUBCHEM_BIOASSAY: Image-Based HTS for Selective Antagonists of GPR35. High content imaging assay of the inhibition of receptor-mediated beta-arrestin GFP translocation to cytosolic compartments Secondary Screen (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2079, AID2397, AID2480, AID463201, AID463202, AID463217, AID463227, AID463228, AID488987]
ChEMBL 321 1 1 6 2.1 CN1CC=C2C(C#N)=C(N)C(C#N)(C#N)C(c3ccsc3)C2C1 nan
18158890 23518 3 None - 1 Human 5.0 pIC50 = 5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
CHEMBL1333832 23518 3 None - 1 Human 5.0 pIC50 = 5 Functional
PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells. (Class of assay: confirmatory) [Related pubchem assays: 2079, 2058 ]
ChEMBL 404 8 2 4 2.8 CC(C)(C)c1ccc(OCCC(=O)NCCc2ccc(S(N)(=O)=O)cc2)cc1 nan
4659569 22331 101 None 4 5 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
CHEMBL1324 22331 101 None 4 5 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 None
5281081 207656 87 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
CHEMBL953 207656 87 None - 1 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 None
2882 1208 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1208 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1208 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1208 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1208 62 None -2 5 Mouse 8.3 pEC50 = 8.3 Functional
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
2161 8733 121 None 154 3 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
CHEMBL1096 8733 121 None 154 3 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
Drug Central 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 None
2471 739 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
427 739 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
4837 739 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
CHEMBL1072 739 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
DB00887 739 109 None 18 3 Human 8.3 pEC50 = 8.3 Functional
NoneNone
Drug Central 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O None
2882 1208 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1208 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1208 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1208 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1208 62 None 2 5 Rat 8.2 pEC50 = 8.2 Functional
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
50294 217718 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 371 5 2 6 2.5 CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O None
3325 2338 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
44564 2338 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
9743 2338 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
CHEMBL1201266 2338 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
DB06794 2338 56 None - 1 Human 8.1 pEC50 = 8.1 Functional
GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2
Drug Central 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl None
3325 2338 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
44564 2338 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
9743 2338 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
CHEMBL1201266 2338 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
DB06794 2338 56 None - 1 Human 9.0 pEC50 = 9 Functional
In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.In an AP-TGF-α shedding assay using GPR35 expressing HEK293 cells.
Guide to Pharmacology 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 29068046
2918 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
3845 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
CHEMBL299155 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
DB11937 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2204 126 None -2630 4 Human 4.2 pEC50 = 4.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 23396314
2471 739 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
427 739 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
4837 739 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
CHEMBL1072 739 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
DB00887 739 109 None 18 3 Human 5.3 pEC50 = 5.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 364 8 3 5 3.0 CCCCNc1cc(cc(c1Oc1ccccc1)S(=O)(=O)N)C(=O)O 22236570
118985385 1701 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
1258 1701 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
3440 1701 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
4839 1701 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
CHEMBL35 1701 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
DB00695 1701 111 None 7 2 Human 5.4 pEC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 22236570
2936 85 0 None -3 4 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
56947016 85 0 None -3 4 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 436 20 3 5 5.0 CCCCCCCC/C=C\CCCCCCCC(=O)OC(COP(=O)(O)O)CO 20361937
2920 2997 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 2997 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 2997 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 2997 103 None -3388 2 Rat 4.0 pEC50 None 4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
2918 2204 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2204 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2204 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2204 126 None -616 4 Mouse 5.0 pEC50 None 5.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
2918 2204 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
3845 2204 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
CHEMBL299155 2204 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
DB11937 2204 126 None -1202 4 Rat 5.2 pEC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 16754668
135399235 4134 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 4134 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 4134 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 4134 60 None -18 3 Human 6.1 pEC50 None 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2920 2997 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
54742459 2997 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
8546 2997 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
CHEMBL177880 2997 103 None 3388 2 Human 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 20919992
135399235 4134 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
2919 4134 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5722 4134 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
CHEMBL28079 4134 60 None 18 3 Rat 7.8 pEC50 None 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 16934253
5280343 188275 124 None -8 12 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL1520590 188275 124 None -8 12 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
CHEMBL50 188275 124 None -8 12 Human 8.3 pIC50 = 8.3 Functional
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
Drug Central 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 None
2745687 933 31 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 933 31 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 933 31 None 10 3 Human 6.7 pIC50 = 6.7 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.Antagonism of zaprinast-mediated activation of GPR35 in a β-arrestin assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
2745687 933 31 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 933 31 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 933 31 None 10 3 Human 5.0 pIC50 = 5.0 Functional
Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.Antagonism of zaprinast-mediated activation of GPR35 in a dynamic mass redistribution assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

135399235 4134 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
2919 4134 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
5722 4134 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
CHEMBL28079 4134 60 None - 1 Human 9.2 pEC50 = 9.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
12138435 68057 29 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 68057 29 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
71733650 90843 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90843 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
694463 87480 90 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 87480 90 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733848 90861 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 90861 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
71733848 90861 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90861 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
71733848 90861 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90861 0 None - 1 Human 8.0 pEC50 = 8.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
135399235 4134 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 4134 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 4134 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 4134 60 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733845 90858 0 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90858 0 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
4488 203021 110 None - 1 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 203021 110 None - 1 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733651 90844 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 90844 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733651 90844 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90844 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71734940 90845 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
CHEMBL2392163 90845 0 None - 1 Human 7.0 pEC50 = 7.0 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm400587g
118985385 1701 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1701 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1701 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1701 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1701 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1701 111 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733650 90843 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90843 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733843 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2392174 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
CHEMBL2425818 90856 6 None - 1 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/acs.jmedchem.6b01431
2920 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
2920 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 103 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71734944 90830 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 90830 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
71733653 90847 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 90847 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 1208 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1208 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1208 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1208 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1208 62 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71734939 90826 1 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392144 90826 1 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 90860 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90860 0 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
92934 169657 95 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 169657 95 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in human HT29 cells by DMR assayAgonist activity at human GPR35 expressed in human HT29 cells by DMR assay
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
12403015 111496 1 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL3277775 111496 1 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 300 2 4 4 0.8 O=C(O)c1cc(=O)c2c(ccc3c(=O)cc(C(=O)O)[nH]c32)[nH]1 10.1021/acs.jmedchem.6b01431
135399235 4134 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 4134 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 4134 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 4134 60 None - 1 Human 6.9 pEC50 = 6.9 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
54676038 38723 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1466 38723 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
54676038 38723 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38723 77 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
71733846 90859 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90859 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71735030 90834 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 90834 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735030 90834 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 90834 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71734942 90828 0 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392146 90828 0 None - 1 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
271643 32780 70 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 32780 70 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71733844 90857 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 90857 0 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735034 90837 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392155 90837 0 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
10857978 115245 6 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 115245 6 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
137652009 157514 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157514 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137652009 157514 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157514 0 None - 0 Human 7.9 pEC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733848 90861 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90861 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
2295463 92221 34 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 92221 34 None - 1 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
71733843 90856 6 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90856 6 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90856 6 None - 1 Rat 5.9 pEC50 = 5.9 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137657450 159595 3 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159595 3 None - 0 Human 4.9 pEC50 = 4.9 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 159595 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159595 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137657450 159595 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159595 3 None - 0 Human 5.9 pEC50 = 5.9 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733651 90844 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90844 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733939 90864 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 90864 0 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
137636652 156049 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 156049 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
13950958 157628 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157628 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733749 90854 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90854 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71733749 90854 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90854 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
13950958 157628 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157628 4 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
4488 203021 110 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 203021 110 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assayAgonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
137653726 158676 3 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158676 3 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733939 90864 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
CHEMBL2392182 90864 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm400587g
71735035 90838 0 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
CHEMBL2392156 90838 0 None - 1 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm400587g
71733748 90853 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90853 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733748 90853 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 90853 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733748 90853 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90853 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 90849 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 90849 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 90849 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90849 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733649 90842 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90842 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
71733744 90849 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90849 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
135399235 4134 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 60 None - 1 Human 6.8 pEC50 = 6.8 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733845 90858 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90858 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733845 90858 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90858 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733649 90842 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90842 0 None - 1 Human 7.8 pEC50 = 7.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135468531 90824 25 None - 0 Mouse 4.8 pEC50 = 4.8 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90824 25 None - 0 Mouse 4.8 pEC50 = 4.8 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733743 90848 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 90848 0 None - 1 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
5464105 57832 67 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 57832 67 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
725495 65536 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65536 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
725495 65536 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65536 66 None - 0 Human 5.8 pEC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
71733651 90844 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392162 90844 0 None - 1 Rat 5.8 pEC50 = 5.8 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137655259 158968 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 158968 3 None - 0 Human 4.8 pEC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11312 111518 63 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 111518 63 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71733744 90849 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90849 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
4921319 107461 58 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 107461 58 None - 0 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
135399235 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
137662152 159391 9 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159391 9 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
2920 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2997 103 None - 1 Human 8.7 pEC50 = 8.7 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733649 90842 0 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392160 90842 0 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
657910 53452 53 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 53452 53 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
71734943 90829 0 None - 1 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 90829 0 None - 1 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733847 90860 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90860 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
71733746 90851 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90851 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
2882 1208 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1208 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1208 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1208 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1208 62 None - 1 Human 6.7 pEC50 = 6.7 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
71733653 90847 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392165 90847 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3254949 115246 6 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 115246 6 None - 0 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
782693 158241 32 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 158241 32 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
71735036 90839 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90839 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733843 90856 6 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392174 90856 6 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2425818 90856 6 None - 1 Human 7.7 pEC50 = 7.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
3870203 58330 55 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL168276 58330 55 None - 0 Human 4.7 pEC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 200 2 2 6 0.9 O=[N+]([O-])c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
135399235 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 60 None - 1 Human 5.7 pEC50 = 5.7 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
71733842 90855 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 90855 0 None - 1 Rat 5.7 pEC50 = 5.7 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137658268 159662 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159662 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
137658268 159662 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159662 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
633803 115247 11 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 115247 11 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734941 90827 2 None - 1 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392145 90827 2 None - 1 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10857978 115245 6 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
CHEMBL3347429 115245 6 None - 0 Human 4.6 pEC50 = 4.6 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 252 2 1 5 2.5 O=[N+]([O-])c1cc([N+](=O)[O-])c(Cl)c(Cl)c1O 10.1039/C2MD20210G
71733747 90852 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 90852 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
71733749 90854 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 90854 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733747 90852 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 90852 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
73294510 92219 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 92219 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
135468531 90824 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90824 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
135468531 90824 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90824 25 None - 0 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733650 90843 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392161 90843 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137646097 157900 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 157900 3 None - 0 Human 5.6 pEC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
71733749 90854 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90854 0 None - 1 Human 7.6 pEC50 = 7.6 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
71735032 90835 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 90835 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
71733745 90850 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 90850 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
71733744 90849 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392167 90849 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733652 90846 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 90846 0 None - 1 Rat 5.6 pEC50 = 5.6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
137652009 157514 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157514 0 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137647862 157653 3 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 157653 3 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
633803 115247 11 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347475 115247 11 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 408 6 2 10 3.1 CC(C)(c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1)c1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71734946 90833 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 90833 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
2920 2997 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 103 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
137662152 159391 9 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assayAgonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
CHEMBL4100677 159391 9 None - 1 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assayAgonist activity at GPR-35 in human HT-29 cells incubated for 1 hr by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
135468531 90824 25 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
CHEMBL2392141 90824 25 None - 0 Human 8.5 pEC50 = 8.5 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm4009373
71733940 90865 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90865 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733940 90865 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90865 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
71733745 90850 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 90850 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733745 90850 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392168 90850 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4488 203021 110 None - 1 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 203021 110 None - 1 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
1493 98090 76 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL273386 98090 76 None - 0 Human 4.5 pEC50 = 4.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
71733648 90841 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90841 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733743 90848 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
CHEMBL2392166 90848 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm400587g
12138435 68057 29 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
CHEMBL1914576 68057 29 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.6b01431
135399235 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
2919 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
5722 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
CHEMBL28079 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1039/C2MD20210G
71733749 90854 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
CHEMBL2392172 90854 0 None - 1 Rat 5.5 pEC50 = 5.5 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm400587g
137648473 157992 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 157992 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137648473 157992 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 157992 3 None - 0 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
71733748 90853 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
CHEMBL2392171 90853 0 None - 1 Human 7.5 pEC50 = 7.5 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm400587g
135399235 4134 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 60 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
40119 84805 24 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
CHEMBL22336 84805 24 None - 0 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assayAgonist activity at recombinant human N-terminal FLAG/eYFP-fused GPR35a expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment by path hunter assay
ChEMBL 312 1 1 6 1.2 O=C1c2ccccc2S(=O)(=O)c2cc(-c3nn[nH]n3)ccc21 10.1021/acsmedchemlett.7b00510
71735036 90839 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 90839 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 90839 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90839 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71735036 90839 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90839 0 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
2295463 92221 34 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 92221 34 None - 1 Human 6.5 pEC50 = 6.5 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
135399235 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 60 None - 1 Human 5.5 pEC50 = 5.5 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71735030 90834 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
CHEMBL2392152 90834 0 None - 1 Mouse 5.5 pEC50 = 5.5 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm400587g
71733938 90863 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392181 90863 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
13950958 157628 4 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157628 4 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
11872 107463 66 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 107463 66 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
73294509 92218 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 92218 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733648 90841 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90841 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
71733842 90855 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392173 90855 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
73294321 92217 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 92217 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294320 92216 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 92216 0 None - 1 Human 8.4 pEC50 = 8.4 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
71733747 90852 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
CHEMBL2392170 90852 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm400587g
3325 2338 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
44564 2338 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
9743 2338 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
CHEMBL1201266 2338 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
DB06794 2338 56 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 311 2 4 5 0.3 N#Cc1cc(NC(=O)C(=O)O)c(c(c1)NC(=O)C(=O)O)Cl 10.1021/acs.jmedchem.6b01431
2161 8733 121 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
CHEMBL1096 8733 121 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 298 2 2 5 2.7 CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1 10.1021/acs.jmedchem.6b01431
71733848 90861 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
CHEMBL2392179 90861 0 None - 1 Rat 5.4 pEC50 = 5.4 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm400587g
13681 115244 67 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 115244 67 None - 0 Human 4.4 pEC50 = 4.4 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL5285029 194275 0 None - 1 Human 7.4 pEC50 = 7.4 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71734944 90830 0 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
CHEMBL2392148 90830 0 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm400587g
135399235 4134 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
2919 4134 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
5722 4134 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
CHEMBL28079 4134 60 None - 1 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acs.jmedchem.6b01431
71733846 90859 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90859 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733846 90859 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90859 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
21236027 158987 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 158987 4 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
71733652 90846 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392164 90846 0 None - 1 Human 6.4 pEC50 = 6.4 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
13950957 157328 7 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 157328 7 None - 0 Human 5.4 pEC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
21982642 90825 2 None - 1 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
CHEMBL2392142 90825 2 None - 1 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm400587g
71734946 90833 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 90833 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
71734946 90833 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
CHEMBL2392151 90833 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm400587g
71735036 90839 0 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90839 0 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 157735 3 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157735 3 None - 0 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1208 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1208 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1208 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1208 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1208 62 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL5281778 194126 0 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71735031 90831 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 90831 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71735031 90831 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
CHEMBL2392149 90831 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm400587g
4659569 22331 101 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 22331 101 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
71733845 90858 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392176 90858 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
71733940 90865 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90865 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
73294508 1140 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 1140 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 1140 0 None - 1 Human 8.3 pEC50 = 8.3 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
137662152 159391 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159391 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137662152 159391 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159391 9 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2920 2997 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
54742459 2997 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
8546 2997 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
CHEMBL177880 2997 103 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm400587g
2920 2997 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
54742459 2997 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
8546 2997 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL177880 2997 103 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acs.jmedchem.6b01431
71735036 90839 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392157 90839 0 None - 1 Mouse 5.3 pEC50 = 5.3 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
137646246 157735 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157735 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137646246 157735 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157735 3 None - 0 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1208 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 1208 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 1208 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 1208 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 1208 62 None - 1 Human 7.3 pEC50 = 7.3 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assayAgonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
2882 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assayAgonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
2882 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1208 62 None - 1 Human 6.3 pEC50 = 6.3 Binding
Agonist activity at human GPR35 by DMR assayAgonist activity at human GPR35 by DMR assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
9492 5469 43 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
CHEMBL107513 5469 43 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1ccc([N+](=O)[O-])c(O)c1 10.1039/C2MD20210G
11872 107463 66 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3183545 107463 66 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
4921319 107461 58 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3183248 107461 58 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 199 2 2 6 0.8 Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735032 90835 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392153 90835 0 None - 1 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
3495594 17189 31 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 17189 31 None - 0 Human 4.3 pEC50 = 4.3 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
13681 115244 67 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL3347428 115244 67 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 218 2 1 5 1.9 O=[N+]([O-])c1cc(Cl)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
1231538 27518 29 None - 0 Human 6.3 pEC50 = 6.3 Binding
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 27518 29 None - 0 Human 6.3 pEC50 = 6.3 Binding
Antagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assayAntagonist activity at human N-terminal HA-tagged GPR35a expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of agonist induced redistribution of GFP-fused beta arrestin-2 preincubated for 15 mins followed by agonist addition by fluorescence assay
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
5281081 207656 87 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 207656 87 None - 0 Human 5.3 pEC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137632988 156368 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 156368 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5288015 194405 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
6191 115242 49 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
CHEMBL3347393 115242 49 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-] 10.1039/C2MD20210G
71733847 90860 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
CHEMBL2392178 90860 0 None - 1 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm400587g
3254949 115246 6 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3347474 115246 6 None - 0 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 460 6 2 10 3.9 O=[N+]([O-])c1cc(C(=C(Cl)Cl)c2cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
73294319 92220 0 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 92220 0 None - 1 Human 8.2 pEC50 = 8.2 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
135399235 4134 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 60 None - 1 Rat 7.2 pEC50 = 7.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
118985385 1701 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1701 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1701 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1701 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1701 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1701 111 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 by Ca+2 release assayAgonist activity at human GPR35 by Ca+2 release assay
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71733846 90859 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90859 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
71733844 90857 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
CHEMBL2392175 90857 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm400587g
71733846 90859 0 None - 1 Mouse 5.2 pEC50 = 5.2 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
CHEMBL2392177 90859 0 None - 1 Mouse 5.2 pEC50 = 5.2 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm400587g
5281081 207656 87 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
CHEMBL953 207656 87 None - 0 Human 4.2 pEC50 = 4.2 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 305 5 2 6 1.8 CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 10.1039/C2MD20210G
137653726 158676 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158676 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
2918 2204 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
3845 2204 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
CHEMBL299155 2204 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
DB11937 2204 126 None - 0 Rat 4.2 pEC50 = 4.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1021/jm400587g
71734943 90829 0 None - 1 Rat 5.2 pEC50 = 5.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392147 90829 0 None - 1 Rat 5.2 pEC50 = 5.2 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
20486870 61097 5 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 61097 5 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
71733647 90840 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 90840 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
137653726 158676 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158676 3 None - 0 Human 7.2 pEC50 = 7.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
10800 163409 59 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 163409 59 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
71735033 90836 0 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
CHEMBL2392154 90836 0 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm400587g
71733746 90851 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90851 0 None - 1 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
137632988 156368 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 156368 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
2882 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at GPR-35 (unknown origin) by beta-arrestin assayAgonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
2882 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
741 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
7608 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
CHEMBL428880 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
DB01003 1208 62 None - 1 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assayAgonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acs.jmedchem.6b01431
137632781 156287 3 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156287 3 None - 0 Human 5.2 pEC50 = 5.2 Binding
Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assayAgonist activity at TEV protease cleavage site linked GAL4-VP16-fused GPR35 in human Tango GPR35-bla U2OS cells assessed as induction of TEV protease-tagged beta-arrestin recruitment incubated for 5 hrs by beta-lactamase reporter gene assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137641148 157047 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 157047 3 None - 0 Human 6.2 pEC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
4659569 22331 101 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
CHEMBL1324 22331 101 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 273 3 2 5 2.5 Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 10.1039/C2MD20210G
11312 111518 63 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL3278560 111518 63 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 184 2 1 5 1.2 O=[N+]([O-])c1cccc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL5289040 194454 0 None - 1 Human 7.1 pEC50 = 7.1 Binding
Agonist activity at GPR-35 in human HT-29 cells by DMR assayAgonist activity at GPR-35 in human HT-29 cells by DMR assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
135468531 90824 25 None - 0 Rat 5.1 pEC50 = 5.1 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
CHEMBL2392141 90824 25 None - 0 Rat 5.1 pEC50 = 5.1 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 342 3 2 4 3.4 O=C1N/C(=N/c2ccccc2F)S/C1=C\c1ccc(C(=O)O)cc1 10.1021/jm400587g
71733647 90840 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
CHEMBL2392158 90840 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm400587g
10800 163409 59 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
CHEMBL419564 163409 59 None - 0 Human 4.1 pEC50 = 4.1 Binding
Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assayAgonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay
ChEMBL 198 2 1 5 1.5 Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O 10.1039/C2MD20210G
5464105 57832 67 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
CHEMBL167055 57832 67 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 265 4 2 6 1.6 CC(=O)C(=Cc1cc(O)c(O)c([N+](=O)[O-])c1)C(C)=O 10.1039/C2MD20210G
137654727 158745 3 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 158745 3 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71733746 90851 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
CHEMBL2392169 90851 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm400587g
5066064 157372 6 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 157372 6 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
3495594 17189 31 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
CHEMBL1256291 17189 31 None - 0 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysisAgonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis
ChEMBL 277 3 2 5 2.4 O=C(c1cc(O)c(O)c([N+](=O)[O-])c1)c1ccccc1F 10.1039/C2MD20210G
71733648 90841 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
CHEMBL2392159 90841 0 None - 1 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35b expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm400587g
137658472 159800 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159800 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137658472 159800 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159800 3 None - 0 Human 6.1 pEC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
71734945 90832 0 None - 1 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
CHEMBL2392150 90832 0 None - 1 Human 5.1 pEC50 = 5.1 Binding
Agonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at human GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm400587g
10752 205817 100 None - 0 Human 4.0 pEC50 = 4.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 205817 100 None - 0 Human 4.0 pEC50 = 4.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
137643561 158052 3 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 158052 3 None - 0 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 156287 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156287 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137632781 156287 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156287 3 None - 0 Human 6.0 pEC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells by DMR assayAgonist activity at GPR35 in human HT-29 cells by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
54676038 38723 77 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38723 77 None - 1 Human 5.0 pEC50 = 5.0 Binding
Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAgonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
135399235 4134 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2919 4134 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
5722 4134 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
CHEMBL28079 4134 60 None - 1 Mouse 6.0 pEC50 = 6.0 Binding
Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm400587g
2882 1208 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
741 1208 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
7608 1208 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
CHEMBL428880 1208 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
DB01003 1208 62 None - 1 Rat 6.0 pEC50 = 6.0 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm400587g
71733940 90865 0 None - 1 Rat 6.0 pEC50 = 6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
CHEMBL2392183 90865 0 None - 1 Rat 6.0 pEC50 = 6 Binding
Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assayAgonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm400587g
5281855 202843 109 None - 0 Human 7.0 pIC50 = 7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
CHEMBL6246 202843 109 None - 0 Human 7.0 pIC50 = 7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 0 4 8 1.3 O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23 10.1021/ml2003058
10752 205817 100 None - 0 Human 4.0 pIC50 = 4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL83294 205817 100 None - 0 Human 4.0 pIC50 = 4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 190 1 1 3 1.5 O=C(O)c1cc2ccccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5289040 194454 0 None - 1 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
2745687 933 31 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 31 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 31 None - 1 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assayAntagonist activity at human GPR35 expressed in human HT29 cells after 1 hr by DMR assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
725495 65536 66 None - 0 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1830823 65536 66 None - 0 Human 6.0 pIC50 = 6.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 346 1 1 3 3.0 O=C(O)c1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
16103462 68069 19 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
CHEMBL1914588 68069 19 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 276 1 1 3 3.7 Cc1c(C(=O)O)sc2c(Br)csc12 10.1021/ml2003058
153273978 195926 4 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
5098885 195926 4 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
CHEMBL559337 195926 4 None - 0 Human 7.0 pIC50 = 7.0 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 248 1 4 5 1.0 O=C(O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 10.1021/ml2003058
694463 87480 90 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL2333943 87480 90 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 268 1 1 3 2.3 O=C(O)c1cc2cc(Br)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
135399235 4134 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
2919 4134 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
5722 4134 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
CHEMBL28079 4134 60 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/ml2003058
4488 203021 110 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
CHEMBL63323 203021 110 None - 1 Human 5.9 pIC50 = 5.9 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/ml2003058
137652009 157514 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4079816 157514 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 320 3 2 10 0.5 O=c1oc2c([N+](=O)[O-])c(O)c([N+](=O)[O-])cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
137635873 155872 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4060393 155872 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 539 6 1 6 5.0 O=C(Nc1ccc2nc([S+]([O-])Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
271643 32780 70 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1414071 32780 70 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 224 1 1 3 2.1 O=C(O)c1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137636652 156049 3 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4062531 156049 3 None - 0 Human 4.9 pIC50 = 4.9 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 322 2 1 6 1.7 COc1cc2oc(=O)c(-c3nnn[nH]3)cc2cc1Br 10.1021/acs.jmedchem.6b01431
137655259 158968 3 None - 0 Human 4.8 pIC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096105 158968 3 None - 0 Human 4.8 pIC50 = 4.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 327 0 0 3 3.2 N#Cc1cc2cc(Br)cc(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
5280343 188275 124 None - 32 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL1520590 188275 124 None - 32 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL50 188275 124 None - 32 Human 4.8 pIC50 = 4.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
411 2593 92 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
5281670 2593 92 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
CHEMBL28626 2593 92 None - 3 Human 5.8 pIC50 = 5.8 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 302 1 5 7 2.0 Oc1ccc(c(c1)O)c1oc2cc(O)cc(c2c(=O)c1O)O 10.1021/ml2003058
137647862 157653 3 None - 0 Human 5.8 pIC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4081445 157653 3 None - 0 Human 5.8 pIC50 = 5.8 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 324 2 0 6 2.3 COc1c(Br)cc2cc(C#N)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
137647638 157638 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
CHEMBL4081331 157638 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 537 6 1 6 6.5 CC(Sc1nc2ccc(NC(=O)c3ccccc3C(=O)N3CCOCC3)cc2s1)c1ccc(Cl)cc1 10.1016/j.bmcl.2016.12.012
5215 2386 132 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
5280445 2386 132 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
CHEMBL151 2386 132 None - 1 Human 4.7 pIC50 = 4.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 286 1 4 6 2.3 Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O 10.1021/ml2003058
2745687 933 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
9741 933 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
CHEMBL1708510 933 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
2745687 933 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 31 None - 1 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
5281672 56554 121 None - 0 Human 5.7 pIC50 = 5.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
CHEMBL164 56554 121 None - 0 Human 5.7 pIC50 = 5.7 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 318 1 6 8 1.7 O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12 10.1021/ml2003058
782693 158241 32 None - 0 Human 4.7 pIC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4088382 158241 32 None - 0 Human 4.7 pIC50 = 4.7 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 205 0 0 3 2.3 N#Cc1cc2cc(Cl)ccc2oc1=O 10.1021/acs.jmedchem.6b01431
137653726 158676 3 None - 0 Human 7.6 pIC50 = 7.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4092954 158676 3 None - 0 Human 7.6 pIC50 = 7.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 386 1 2 6 2.2 O=c1oc2c(Br)c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
657910 53452 53 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL1600989 53452 53 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 258 1 1 3 2.8 O=C(O)c1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
2286812 29466 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
CHEMBL1384502 29466 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at GPR-35 (unknown origin) by beta-arrestin assayAntagonist activity at GPR-35 (unknown origin) by beta-arrestin assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
2286812 29466 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29466 35 None - 1 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assayAntagonist activity at human Gal4-VP16 fused GPR35 expressed in human U2OS cells assessed as beta arrestin translocation by reporter gene assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646097 157900 3 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
CHEMBL4084237 157900 3 None - 0 Human 5.6 pIC50 = 5.6 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 367 3 1 8 1.7 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1[N+](=O)[O-] 10.1021/acs.jmedchem.6b01431
5281605 205732 114 None - 0 Human 4.6 pIC50 = 4.6 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
CHEMBL8260 205732 114 None - 0 Human 4.6 pIC50 = 4.6 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 270 1 3 5 2.6 O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12 10.1021/ml2003058
137658268 159662 3 None - 0 Human 5.5 pIC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4103860 159662 3 None - 0 Human 5.5 pIC50 = 5.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 343 0 1 4 2.9 N#Cc1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
135403802 26531 56 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
CHEMBL1360563 26531 56 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 300 0 4 6 1.3 O=C1C=C2CC3(O)COc4c(ccc(O)c4O)C3=C2C=C1O 10.1021/ml2003058
5328791 204984 64 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
CHEMBL76602 204984 64 None - 0 Human 4.5 pIC50 = 4.5 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 189 2 2 3 1.4 N#C/C(=C\c1ccc(O)cc1)C(=O)O 10.1021/ml2003058
137646246 157735 3 None - 0 Human 7.5 pIC50 = 7.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4082281 157735 3 None - 0 Human 7.5 pIC50 = 7.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 329 2 2 6 1.9 O=C(O)c1cc2cc(Br)c(O)c([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
137648473 157992 3 None - 0 Human 6.5 pIC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4085211 157992 3 None - 0 Human 6.5 pIC50 = 6.5 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 337 2 1 7 1.6 O=c1oc2c([N+](=O)[O-])cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
21236027 158987 4 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4096323 158987 4 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 313 2 1 5 2.2 O=C(O)c1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
13950957 157328 7 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4077503 157328 7 None - 0 Human 5.4 pIC50 = 5.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 284 1 2 4 2.0 O=C(O)c1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
137632781 156287 3 None - 0 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4065291 156287 3 None - 0 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 370 1 1 5 2.5 O=c1oc2c(Br)cc(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5491415 75292 19 None - 0 Human 6.4 pIC50 = 6.4 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
CHEMBL2037378 75292 19 None - 0 Human 6.4 pIC50 = 6.4 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 537 6 8 10 1.7 CC(=O)NCCc1ccc(O)c(-c2c(O)c(O)c3c(c2O)C(=O)c2c(cc(O)c(C(=O)O)c2C(=O)O)C3=O)c1 10.1021/ml2003058
2918 2204 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
3845 2204 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
CHEMBL299155 2204 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
DB11937 2204 126 None - 0 Human 4.4 pIC50 = 4.4 Binding
Antagonist activity at GPR35 (unknown origin)Antagonist activity at GPR35 (unknown origin)
ChEMBL 189 1 2 2 1.2 OC(=O)c1cc(=O)c2c([nH]1)cccc2 10.1016/j.bmcl.2016.12.012
CHEMBL5285029 194275 0 None - 1 Human 6.4 pIC50 = 6.4 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
73157 195359 30 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
CHEMBL551842 195359 30 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 456 10 2 7 5.5 CCCCCc1c2c(cc(O)c1C(=O)O)OC(=O)c1c(cc(OC)cc1C(=O)CCCC)O2 10.1021/ml2003058
1231538 27518 29 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1368962 27518 29 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 523 6 1 6 6.0 O=C(Nc1ccc2nc(SCc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137657450 159595 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4103143 159595 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 400 2 1 6 2.5 COc1c(Br)cc2cc(-c3nnn[nH]3)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
3884 44498 77 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
CHEMBL15193 44498 77 None - 0 Human 5.3 pIC50 = 5.3 Binding
Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 minsDesensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins
ChEMBL 242 2 1 3 3.2 CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O 10.1021/ml2003058
137641148 157047 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4073902 157047 3 None - 0 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 308 1 2 6 1.4 O=c1oc2cc(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL5285029 194275 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
20486870 61097 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
CHEMBL1765162 61097 5 None - 0 Human 5.3 pIC50 = 5.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 214 1 1 5 1.0 O=c1oc2ccccc2cc1-c1nn[nH]n1 10.1021/acs.jmedchem.6b01431
2286812 29466 35 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29466 35 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
137646699 157737 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL4082295 157737 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 555 6 1 7 4.6 O=C(Nc1ccc2nc(S(=O)(=O)Cc3ccc(Cl)cc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL5281778 194126 0 None - 1 Human 6.3 pIC50 = 6.3 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
13950958 157628 4 None - 1 Human 7.3 pIC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4081238 157628 4 None - 1 Human 7.3 pIC50 = 7.3 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acs.jmedchem.6b01431
2745687 933 31 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 31 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 31 None - 1 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assayAntagonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
137654727 158745 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4093683 158745 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 357 1 0 4 3.2 COc1c(Br)cc2cc(C#N)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
137632988 156368 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4066109 156368 3 None - 0 Human 6.2 pIC50 = 6.2 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 294 1 0 5 2.3 N#Cc1cc2cc(Br)cc([N+](=O)[O-])c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5288015 194405 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
5346366 41498 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
CHEMBL1490915 41498 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effectAntagonist activity at HA tagged GPR35a (unknown origin) expressed in human U2OS cells co-expressing GFP-fused beta arrestin-2 assessed as inhibition of zaprinast induced effect
ChEMBL 489 6 1 6 5.3 O=C(Nc1ccc2nc(SCc3ccccc3)sc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmcl.2016.12.012
137658472 159800 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL4105535 159800 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 376 2 1 4 3.0 COc1c(Br)cc2cc(C(=O)O)c(=O)oc2c1Br 10.1021/acs.jmedchem.6b01431
CHEMBL5288015 194405 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation in presence of ML-145
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
137662152 159391 9 None - 1 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
CHEMBL4100677 159391 9 None - 1 Human 8.1 pIC50 = 8.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acs.jmedchem.6b01431
5066064 157372 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4078055 157372 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 239 0 0 3 3.0 N#Cc1cc2cc(Cl)cc(Cl)c2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL5281778 194126 0 None - 1 Human 8.0 pIC50 = 8.0 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5289040 194454 0 None - 1 Human 8.0 pIC50 = 8.0 Binding
Agonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulationAgonist activity at GPR-35 in human HT-29 cells assessed as desensitization of zaprinast induced DMR response incubated for 1 hr followed by zaprinast stimulation
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
137643561 158052 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
CHEMBL4085935 158052 3 None - 0 Human 5.0 pIC50 = 5.0 Binding
Agonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assayAgonist activity at GPR35 in human HT-29 cells assessed as induction of cell desensitization to 1 uM zaprinast preincubated for 1 hr followed by zaprinast stimulation measured after 8 minutes by DMR assay
ChEMBL 265 0 1 4 2.1 N#Cc1cc2cc(Br)c(O)cc2oc1=O 10.1021/acs.jmedchem.6b01431
71733843 90856 6 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90856 6 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90856 6 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2Binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in absence of MgCl2, NaCl, CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL5288015 194405 0 None - 1 Human 7.8 pKd = 7.8 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 806 14 3 13 5.4 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCOCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5281778 194126 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 790 13 3 12 6.2 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
71733843 90856 6 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90856 6 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90856 6 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysisBinding affinity to human recombinant GPR35 expressed in CHO cells after 150 mins by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 90856 6 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90856 6 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90856 6 None - 1 Human 8.3 pKd = 8.3 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of MgCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733843 90856 6 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90856 6 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90856 6 None - 1 Human 8.2 pKd = 8.2 Binding
Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2Competitive binding affinity to human recombinant GPR35 expressed in CHO cells by scintillation counting analysis in presence of CaCl2
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL5289040 194454 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 776 12 3 12 5.8 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
CHEMBL5285029 194275 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assayBinding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells using furimazine as substrate incubated for 30 mins in presence of zaprinast followed by substrate addition by BERT-based equilibrium binding assay
ChEMBL 804 14 3 12 6.6 CC1=CC(C)=[N+]2C1=C(c1ccc(OCCn3cc(CCCCCOc4cc(C(=O)O)nc5c(C)c6nc(C(=O)O)cc(O)c6cc45)nn3)cc1)c1nc(C)cn1[B-]2(F)F 10.1021/acsmedchemlett.2c00461
73294508 1140 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
9742 1140 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
CHEMBL2425821 1140 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 10.1021/jm4009373
71733748 90853 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392171 90853 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(O)c1cc(=O)c2cc(Br)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733848 90861 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
CHEMBL2392179 90861 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 451 4 2 5 4.2 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(Cl)c1 10.1021/jm4009373
73294320 92216 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425819 92216 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
73294321 92217 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
CHEMBL2425820 92217 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 435 4 2 5 3.7 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1F 10.1021/jm4009373
73294319 92220 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
CHEMBL2425824 92220 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 391 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c(F)c1 10.1021/jm4009373
145971442 163027 0 None - 1 Human 8.0 pKi = 8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.2c00461
CHEMBL4175848 163027 0 None - 1 Human 8.0 pKi = 8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 373 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(Br)ccc2-c2nnn[nH]2)cc1 10.1021/acsmedchemlett.2c00461
2920 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 50 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71735035 90838 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
CHEMBL2392156 90838 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 377 3 2 4 3.8 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(C(F)(F)F)cc1 10.1021/jm4009373
2920 2997 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
54742459 2997 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
8546 2997 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
CHEMBL177880 2997 103 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/jm4009373
71733650 90843 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392161 90843 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(Nc1cc(F)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71733648 90841 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
CHEMBL2392159 90841 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3cccc(Cl)c3Cl)c2o1 10.1021/jm4009373
71733746 90851 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392169 90851 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 401 3 2 4 3.8 Cc1cccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
21982642 90825 2 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
CHEMBL2392142 90825 2 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 235 2 1 5 1.4 O=C(O)c1cc(=O)c2cccc([N+](=O)[O-])c2o1 10.1021/jm4009373
71733652 90846 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392164 90846 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 343 3 2 4 3.4 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
2920 2997 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 103 None - 1 Human 7.8 pKi = 7.8 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 20 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733842 90855 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392173 90855 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 412 3 2 5 3.4 N#Cc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733847 90860 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
CHEMBL2392178 90860 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 3 2 6 3.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc2c(c1)OCO2 10.1021/jm4009373
71733743 90848 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
CHEMBL2392166 90848 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 388 4 2 6 3.3 O=C(Nc1cc(Cl)cc2c(=O)cc(C(=O)O)oc12)c1ccc([N+](=O)[O-])cc1 10.1021/jm4009373
71734941 90827 2 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392145 90827 2 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 247 2 2 4 1.5 CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734943 90829 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392147 90829 0 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 305 4 2 6 1.0 COC(=O)CC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71734940 90845 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
CHEMBL2392163 90845 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 385 5 1 6 3.4 CCOC(=O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(OC)cc3)c2o1 10.1021/jm4009373
71733749 90854 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL2392172 90854 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 455 3 2 4 4.8 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
73294510 92219 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425823 92219 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 369 5 2 6 2.8 COc1ccc(C(=O)Nc2cc(OC)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735036 90839 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392157 90839 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 339 4 2 5 2.8 COc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733846 90859 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
CHEMBL2392177 90859 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 447 5 2 6 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1OC 10.1021/jm4009373
2920 2997 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 103 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733647 90840 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
CHEMBL2392158 90840 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(Br)cc1 10.1021/jm4009373
2882 1208 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
741 1208 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
7608 1208 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
CHEMBL428880 1208 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
DB01003 1208 62 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/jm4009373
2745687 933 31 None - 1 Human 6.6 pKi = 6.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
9741 933 31 None - 1 Human 6.6 pKi = 6.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
CHEMBL1708510 933 31 None - 1 Human 6.6 pKi = 6.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/acsmedchemlett.2c00461
71733651 90844 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392162 90844 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 4 2 5 2.9 COc1ccc(C(=O)Nc2cc(F)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733940 90865 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
CHEMBL2392183 90865 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cn1 10.1021/jm4009373
71733653 90847 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392165 90847 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 357 3 2 4 3.7 Cc1cccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71734945 90832 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392150 90832 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 4 2 4 2.7 O=C(Cc1ccccc1)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
154634314 186609 0 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acsmedchemlett.2c00461
CHEMBL4878979 186609 0 None - 1 Human 7.6 pKi = 7.6 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 408 4 2 7 3.0 COc1ccccc1-c1cc2cc(C(=O)O)c(=O)oc2c2cc(C(=O)O)c(=O)oc12 10.1021/acsmedchemlett.2c00461
2882 1208 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
741 1208 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
7608 1208 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL428880 1208 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
DB01003 1208 62 None - 1 Human 5.5 pKi = 5.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O 10.1021/acsmedchemlett.2c00461
71734939 90826 1 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392144 90826 1 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 283 1 2 4 1.8 Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
118985385 1701 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
1258 1701 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
3440 1701 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
4839 1701 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
CHEMBL35 1701 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
DB00695 1701 111 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N 10.1021/jm4009373
71735031 90831 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392149 90831 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 309 3 2 4 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
71733845 90858 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392176 90858 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccccc1C(=O)Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
1024 16488 106 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acsmedchemlett.2c00461
CHEMBL1235421 16488 106 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 330 3 4 6 0.6 O=C(O)c1cc(C(=O)O)c2c(n1)C(=O)C(=O)c1cc(C(=O)O)[nH]c1-2 10.1021/acsmedchemlett.2c00461
13950958 157628 4 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acsmedchemlett.2c00461
CHEMBL4081238 157628 4 None - 1 Human 6.5 pKi = 6.5 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 362 1 2 4 2.7 O=C(O)c1cc2cc(Br)c(O)c(Br)c2oc1=O 10.1021/acsmedchemlett.2c00461
71734944 90830 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
CHEMBL2392148 90830 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 315 3 2 4 3.0 O=C(O)c1cc(=O)c2cccc(NC(=O)C3CCCCC3)c2o1 10.1021/jm4009373
4488 203021 110 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
CHEMBL63323 203021 110 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 10.1021/jm4009373
71733937 90862 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
CHEMBL2392180 90862 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 379 6 2 5 3.5 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc(OCC2CC2)cc1 10.1021/jm4009373
54676038 38723 77 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
CHEMBL1466 38723 77 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O 10.1021/jm4009373
2286812 29466 35 None - 1 Human 8.4 pKi = 8.4 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
CHEMBL1384502 29466 35 None - 1 Human 8.4 pKi = 8.4 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/acsmedchemlett.2c00461
71733649 90842 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
CHEMBL2392160 90842 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 3 2 4 4.2 O=C(O)c1cc(=O)c2cc(F)cc(NC(=O)c3ccc(Cl)cc3Cl)c2o1 10.1021/jm4009373
71733747 90852 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
CHEMBL2392170 90852 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 421 3 2 4 4.2 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccc(Cl)cc1 10.1021/jm4009373
135399235 4134 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2919 4134 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
5722 4134 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
CHEMBL28079 4134 60 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/jm4009373
2745687 933 31 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
9741 933 31 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
CHEMBL1708510 933 31 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 10.1021/jm4009373
73294509 92218 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425822 92218 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 353 4 2 5 3.1 COc1ccc(C(=O)Nc2cc(C)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71735033 90836 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
CHEMBL2392154 90836 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 354 4 2 6 2.7 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1cccc([N+](=O)[O-])c1 10.1021/jm4009373
71735032 90835 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
CHEMBL2392153 90835 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1cccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)c1 10.1021/jm4009373
71733843 90856 6 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392174 90856 6 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2425818 90856 6 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 417 4 2 5 3.5 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733744 90849 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392167 90849 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 373 4 2 5 3.4 COc1ccc(C(=O)Nc2cc(Cl)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
2295463 92221 34 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
CHEMBL2425825 92221 34 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 279 4 2 5 1.5 O=C(O)COc1ccc(/C=C2\SC(=O)NC2=O)cc1 10.1021/jm4009373
137662152 159391 9 None - 1 Human 7.3 pKi = 7.3 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
CHEMBL4100677 159391 9 None - 1 Human 7.3 pKi = 7.3 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 353 2 2 8 1.3 O=c1oc2c([N+](=O)[O-])c(O)c(Br)cc2cc1-c1nnn[nH]1 10.1021/acsmedchemlett.2c00461
71733939 90864 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
CHEMBL2392182 90864 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 418 4 2 6 2.9 COc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)nc1 10.1021/jm4009373
326869 112811 5 None - 1 Human 8.2 pKi = 8.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acsmedchemlett.2c00461
CHEMBL3306990 112811 5 None - 1 Human 8.2 pKi = 8.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 314 2 4 4 1.1 Cc1c2[nH]c(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)[nH]c12 10.1021/acsmedchemlett.2c00461
135399235 4134 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
2919 4134 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
5722 4134 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
CHEMBL28079 4134 60 None - 1 Human 6.2 pKi = 6.2 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 271 4 2 5 1.4 CCCOc1ccccc1c1nc(=O)c2c(n1)[nH][nH]n2 10.1021/acsmedchemlett.2c00461
12138435 68057 29 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
CHEMBL1914576 68057 29 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 329 1 0 4 4.4 CC1=C(C#N)C(=C(C#N)C#N)OC1(C)c1ccc(Cl)c(Cl)c1 10.1021/jm4009373
71734942 90828 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
CHEMBL2392146 90828 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 261 3 2 4 1.8 CCC(=O)Nc1cccc2c(=O)cc(C(=O)O)oc12 10.1021/jm4009373
71735030 90834 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
CHEMBL2392152 90834 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 360 3 2 5 3.3 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2n1 10.1021/jm4009373
71735034 90837 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392155 90837 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 323 3 2 4 3.1 Cc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71734946 90833 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
CHEMBL2392151 90833 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 359 3 2 4 3.9 O=C(Nc1cccc2c(=O)cc(C(=O)O)oc12)c1ccc2ccccc2c1 10.1021/jm4009373
2286812 29466 35 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
CHEMBL1384502 29466 35 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 482 8 3 6 4.7 CC(/C=C1\SC(=S)N(CCCC(=O)Nc2ccc(C(=O)O)c(O)c2)C1=O)=C\c1ccccc1 10.1021/jm4009373
2920 2997 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 103 None - 1 Human 8.1 pKi = 8.1 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 40 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733938 90863 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392181 90863 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 367 6 2 5 3.5 CCCOc1ccc(C(=O)Nc2cccc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
71733745 90850 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
CHEMBL2392168 90850 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 387 3 2 4 3.5 O=C(Nc1cc(Br)cc2c(=O)cc(C(=O)O)oc12)c1ccccc1 10.1021/jm4009373
2920 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
54742459 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
8546 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
CHEMBL177880 2997 103 None - 1 Human 8.0 pKi = 8.0 Binding
Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uideCompetitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 100 nM of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide
ChEMBL 388 4 4 4 4.4 OC(=O)c1cc2ccccc2c(c1O)Cc1c(O)c(cc2c1cccc2)C(=O)O 10.1021/acsmedchemlett.2c00461
71733844 90857 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
CHEMBL2392175 90857 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 431 5 2 5 3.9 CCOc1ccc(C(=O)Nc2cc(Br)cc3c(=O)cc(C(=O)O)oc23)cc1 10.1021/jm4009373
92934 169657 95 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
CHEMBL443738 169657 95 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
ChEMBL 280 2 2 6 1.9 O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1 10.1021/jm4009373
4488 203021 110 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
CHEMBL63323 203021 110 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 282 3 2 3 3.5 O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 None
118985385 1701 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
1258 1701 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
3440 1701 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
4839 1701 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
CHEMBL35 1701 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
DB00695 1701 111 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 330 5 3 5 1.9 OC(=O)c1cc(c(cc1NCc1ccco1)Cl)S(=O)(=O)N None
2882 1208 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
741 1208 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
7608 1208 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
CHEMBL428880 1208 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
DB01003 1208 62 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 468 8 3 9 2.1 OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O None
54676038 38723 77 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
CHEMBL1466 38723 77 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysisDisplacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis
Drug Central 336 2 2 6 2.9 O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O None
2745687 933 31 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
9741 933 31 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
CHEMBL1708510 933 31 None - 1 Human 7.9 pKi = 7.9 Binding
Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.Antagonism of the GPR35 response to 1 μM pamoic acid in a βarrestin2-GFP trafficking assay.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 20826425
2745687 933 31 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
9741 933 31 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
CHEMBL1708510 933 31 None - 1 Human 7.4 pKi = 7.4 Binding
In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.In a competition radiologand binding assay membranes preapred from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 395 4 2 6 2.5 COC(=O)c1cnn(c1C=NNC(=S)NC(C)(C)C)c1ccc(cc1F)F 23888932
73294508 1140 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
9742 1140 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932
CHEMBL2425821 1140 0 None - 1 Human 9.2 pKi = 9.2 Binding
In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.In a radioligand competition binding assay using membranes prepared from CHO cells recombinantly expressing human GPR35.
Guide to Pharmacology 453 4 2 5 3.8 COc1cc(F)c(c(c1)F)C(=O)Nc1cc(Br)cc2c1oc(cc2=O)C(=O)O 23888932